| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
|
27 |
S9 |
p. viii
|
artikel
|
| 2 |
drug index
|
|
|
|
27 |
S9 |
p. ix192-ix193
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
27 |
S9 |
p. i-ii
|
artikel
|
| 4 |
ESMO Asia 2016 Officers
|
|
|
|
27 |
S9 |
p. v-vi
|
artikel
|
| 5 |
LBA3 Expectations and acceptance of nurse practitioners regarding a health-recording digital platform. Semi-quantitative survey
|
Saadi, A.
|
|
|
27 |
S9 |
p. ix191
|
artikel
|
| 6 |
LBA1 First-line ribociclib 1 letrozole in postmenopausal Asian women with hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): A subgroup analysis from MONALEESA-2
|
Yap, Y.S.
|
|
|
27 |
S9 |
p. ix190
|
artikel
|
| 7 |
LBA2 Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer receiving myelotoxic chemotherapy: Pooled subgroup analysis of two randomized trials
|
Harbeck, N.
|
|
|
27 |
S9 |
p. ix190
|
artikel
|
| 8 |
334O Additional chromosomal abnormalities in chronic myeloid leukemia: Lest we forget
|
Madhav, D.
|
|
|
27 |
S9 |
p. ix104
|
artikel
|
| 9 |
440O Afatinib (A) vs gefitinib (G) in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) sdata from LUX-Lung 7 (LL7)
|
Park, K.
|
|
|
27 |
S9 |
p. ix140-ix141
|
artikel
|
| 10 |
63O A nation-wide multicenter 10-Year (1999-2008) retrospective study of chemotherapy in Chinese breast cancer patients
|
Li, Q.
|
|
|
27 |
S9 |
p. ix19
|
artikel
|
| 11 |
152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours
|
Teneggi, V.
|
|
|
27 |
S9 |
p. ix47
|
artikel
|
| 12 |
300O Assessment of the effectiveness of cervical cancer screening
|
Gvamichava, R.
|
|
|
27 |
S9 |
p. ix95
|
artikel
|
| 13 |
220O Claudin 18.2 - a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer
|
Lordick, F.
|
|
|
27 |
S9 |
p. ix69
|
artikel
|
| 14 |
150O Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
|
Hong, D.S.
|
|
|
27 |
S9 |
p. ix46
|
artikel
|
| 15 |
332O Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells
|
Zhang, H.
|
|
|
27 |
S9 |
p. ix104
|
artikel
|
| 16 |
171O Development of nomogram for predicting lymph node metastases in submucosal colorectal cancer
|
Fujino, S.
|
|
|
27 |
S9 |
p. ix53
|
artikel
|
| 17 |
138O Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM)
|
van den Bent, M.
|
|
|
27 |
S9 |
p. ix42
|
artikel
|
| 18 |
443O EGFR mutations are associated with unfavourable efficacy to anti-PD1 therapy in NSCLC
|
Liu, S.-Y.
|
|
|
27 |
S9 |
p. ix142
|
artikel
|
| 19 |
301O Exploring perceptions of cervical cancer in Dhaka, Bangladesh
|
Islam, N.T.
|
|
|
27 |
S9 |
p. ix95
|
artikel
|
| 20 |
299O Genomic Signature identifying origins of EOC from Fallopiantube and ovary epithelium
|
Di, L.-J.
|
|
|
27 |
S9 |
p. ix94
|
artikel
|
| 21 |
335O Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia
|
Natarajan, H.
|
|
|
27 |
S9 |
p. ix105
|
artikel
|
| 22 |
437O KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced NSCLC with a PD-L1 tumor proportion score (TPS) ≥ 50%
|
Reck, M.
|
|
|
27 |
S9 |
p. ix139
|
artikel
|
| 23 |
170O Lymph node status as a prognostic factor after palliative resection of metastatic colorectal cancer
|
Li, Q.
|
|
|
27 |
S9 |
p. ix53
|
artikel
|
| 24 |
550O Molecular mechanism of transformation from adenocarcinoma to small-cell lung cancer after EGFR-TKI
|
Han, J.
|
|
|
27 |
S9 |
p. ix179
|
artikel
|
| 25 |
442O Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057
|
Reck, M.
|
|
|
27 |
S9 |
p. ix141-ix142
|
artikel
|
| 26 |
116O Palbociclib (PAL) plus letrozole (L) as first-line (1L) therapy (tx) in postmenopausal Asian women with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC)
|
Im, S.-A.
|
|
|
27 |
S9 |
p. ix35
|
artikel
|
| 27 |
361O Patient-reported outcomes (PROs) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) treated with nivolumab (Nivo) or Investigator's Choice (IC): CheckMate 141
|
Kiyota, N.
|
|
|
27 |
S9 |
p. ix113
|
artikel
|
| 28 |
333O Post-transplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in diffuse large B cell lymphoma
|
Ying, Z.
|
|
|
27 |
S9 |
p. ix104
|
artikel
|
| 29 |
395O Potential predictive value for adjuvant PD-1 blockade based on histologic subtype in resected lung adenocarcinoma
|
Dong, Z.-Y.
|
|
|
27 |
S9 |
p. ix123
|
artikel
|
| 30 |
522O_PR Analgesia forcancer paininSoutheast Asia (SEA): Prescription patterns, pain control, treatment satisfaction and quality of life (QoL)
|
Javier, F.O.
|
|
|
27 |
S9 |
p. ix170
|
artikel
|
| 31 |
485O_PR Characterisation and prognostication of pain in advanced cancer - An observational trial
|
Arora, R.D.
|
|
|
27 |
S9 |
p. ix157
|
artikel
|
| 32 |
503O_PR CIC-rearranged sarcoma and BCOR-CCNB3 sarcoma: Clinical characteristics and treatment results of the newly-established “Ewing sarcoma-like” small round cell sarcomas
|
Endo, M.
|
|
|
27 |
S9 |
p. ix164
|
artikel
|
| 33 |
405O_PR Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong
|
Loong, H.H.
|
|
|
27 |
S9 |
p. ix126
|
artikel
|
| 34 |
497O_PR Depression induces poor prognosis via the downregulation of brain derived neurotrophic factor in advanced small cell lung cancer
|
Wu, Y.
|
|
|
27 |
S9 |
p. ix161
|
artikel
|
| 35 |
151O Preclinical characterization of alofanib, a novel allosteric FGFR2 inhibitor
|
Tsimafeyeu, H.
|
|
|
27 |
S9 |
p. ix46-ix47
|
artikel
|
| 36 |
360O_PR Efficacy and safety of nivolumab for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in Asia: CheckMate 141 subgroup analysis
|
Hasegawa, Y.
|
|
|
27 |
S9 |
p. ix112-ix113
|
artikel
|
| 37 |
359O_PR Efficacy and safety of pembrolizumab (MK-3475) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Subset analyses for Asia-pacific patients in KEYNOTE-012 (KN-012) B2 cohort
|
Tahara, M.
|
|
|
27 |
S9 |
p. ix112
|
artikel
|
| 38 |
441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
|
Ma, B.B.Y.
|
|
|
27 |
S9 |
p. ix141
|
artikel
|
| 39 |
501O_PR Epidemiology, real world treatment and outcomes of 423 patients (pts) with angiosarcoma (AS) in Asia: A report from the Asian Sarcoma Consortium (ASC)
|
Quek, R.
|
|
|
27 |
S9 |
p. ix163
|
artikel
|
| 40 |
496O_PR Health-related quality of life and psychological distress among cancer survivors in a middle-income Asian country
|
Subramaniam, S.
|
|
|
27 |
S9 |
p. ix161
|
artikel
|
| 41 |
64O_PR High mammographic breast density predicts locoregional
|
Huang, Y.-S.
|
|
|
27 |
S9 |
p. ix19
|
artikel
|
| 42 |
438O Primary analysis from OAK, a randomized phase III study comparing atezolizumab with docetaxel in 2L/3L NSCLC
|
Park, K.
|
|
|
27 |
S9 |
p. ix139-ix140
|
artikel
|
| 43 |
62O_PR Non-adherence to adjuvant endocrine treatment and its determinants among early stage breast cancer patients
|
Wulaningsih, W.
|
|
|
27 |
S9 |
p. ix19
|
artikel
|
| 44 |
564O_PR Oncologists' preferences for recommending expensive anticancer drugs
|
Karikios, D.J.
|
|
|
27 |
S9 |
p. ix184
|
artikel
|
| 45 |
502O_PR Optimal first line systemic therapy in patients (pts) with metastatic angiosarcoma: A report from the Asian Sarcoma Consortium
|
Chen, T.W.-W.
|
|
|
27 |
S9 |
p. ix163
|
artikel
|
| 46 |
99O_PR Prediction of relapse in patients with locally advanced breast cancer after neoadjuvant treatment
|
Aseyev, O.
|
|
|
27 |
S9 |
p. ix30
|
artikel
|
| 47 |
99O_PR Prediction of relapse in patients with locally advanced breast cancer after neoadjuvant treatment
|
Aseyev, O.
|
|
|
27 |
S9 |
p. ix17
|
artikel
|
| 48 |
565O_PR Predictors of financial catastrophe following cancer in a high-middle-income Asian country
|
Pathy, N. Bhoo
|
|
|
27 |
S9 |
p. ix184
|
artikel
|
| 49 |
484O_PR Validation of the set of six adaptable prognosis prediction (SAP) models for cancer patients in palliative care settings: A sub analysis of the Japan-prognostic assessment tools validation (J-ProVal) study
|
Uneno, Y.
|
|
|
27 |
S9 |
p. ix157
|
artikel
|
| 50 |
168O Right-sided versus left-sided primary tumor location in patients with KRASmut metastatic colorectal cancer (mCRC) treated with 1st-line anti-VEGF plus chemotherapy (CTx) - Data from the National Czech Registry
|
Obermannova, R.
|
|
|
27 |
S9 |
p. ix53
|
artikel
|
| 51 |
219O Safety and preliminary efficacy of nivolumab in patients with advanced hepatocellular carcinoma: interim analysis of the phase 1/2 CheckMate-040 study
|
Melero, I.
|
|
|
27 |
S9 |
p. ix68-ix69
|
artikel
|
| 52 |
297O Stratifying ovarian cancer based on AXL signaling for therapeutic targeting
|
Huang, R.Y.-J.
|
|
|
27 |
S9 |
p. ix94
|
artikel
|
| 53 |
336O Survival patterns of acute lymphoblastic leukemia among adolescents and children in the USA
|
Fadhlullah, I.O.
|
|
|
27 |
S9 |
p. ix105
|
artikel
|
| 54 |
139O Systematic review and individual patient data analysis of uncommon GBM variants: An analysis of 196 cases
|
Mallick, S.
|
|
|
27 |
S9 |
p. ix42
|
artikel
|
| 55 |
337O The changes in the treatment of elderly AML patients in Korea: A single center experience
|
Ryu, H.
|
|
|
27 |
S9 |
p. ix105
|
artikel
|
| 56 |
298O The clinical significance of deregulated cyclin E1 in high grade serous ovarian cancer (HGSOC)
|
Aziz, D.
|
|
|
27 |
S9 |
p. ix94
|
artikel
|
| 57 |
149O The National University Cancer Institute, Singapore (NCIS) Integrated Molecular Analysis of Cancer (IMAC) precision oncology programme: Frequency of actionable mutations and outcomes following matched therapy in an Asian Cancer Centre
|
Syn, N.
|
|
|
27 |
S9 |
p. ix46
|
artikel
|
| 58 |
404O The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients from china
|
Lian, B.
|
|
|
27 |
S9 |
p. ix126
|
artikel
|
| 59 |
439O Tracking spatiotemporal T790M heterogeneity in patients with EGFR-mutant advanced NSCLC after acquired resistance to EGFR TKIs
|
Zhang, Y.-C.
|
|
|
27 |
S9 |
p. ix140
|
artikel
|
| 60 |
329P Accurancy of colposcopy at the Georgian National Screening Center
|
Beruchashvili, T.
|
|
|
27 |
S9 |
p. ix102
|
artikel
|
| 61 |
178P Additional preoperative chemotherapy between preoperative chemoradiotherapy and surgery in patients with locally advanced rectal cancer
|
Choi, J.H.
|
|
|
27 |
S9 |
p. ix56
|
artikel
|
| 62 |
14P Adipose tissue-derived stem cells provide an advantageous tumor microenvironment in gastric cancer
|
Kinoshita, J.
|
|
|
27 |
S9 |
p. ix4
|
artikel
|
| 63 |
15P Adipose tissue vascular promotes tumor growth rate and metastasis
|
Lim, S.
|
|
|
27 |
S9 |
p. ix4-ix5
|
artikel
|
| 64 |
320P Adjuvant chemotherapy comprising a paclitaxel and carboplatin regimen or paclitaxel and ifosfamide regimen for uterine carcinosarcoma, a single institutional retrospective study
|
Ohtake, Y.
|
|
|
27 |
S9 |
p. ix100
|
artikel
|
| 65 |
281P Adrenal tumor and its successful management; a chinese experience & report
|
Kunwar, K.J.
|
|
|
27 |
S9 |
p. ix87-ix88
|
artikel
|
| 66 |
102P Adriamycin/taxanes based neoadjuvant chemotherapy in advanced non-metastatic breast cancer - A single institute experience
|
Yasmeen, H.
|
|
|
27 |
S9 |
p. ix30-ix31
|
artikel
|
| 67 |
384P Afatinib for betel-nut-chewing associated head and neck squamous cell carcinoma - a retrospective analysis
|
Kao, H.-F.
|
|
|
27 |
S9 |
p. ix119
|
artikel
|
| 68 |
411P Ageing of skin cancer patients: a single-institution survey in Japan
|
Sakai, A.
|
|
|
27 |
S9 |
p. ix128
|
artikel
|
| 69 |
135P A multicenter retrospective observation study about overall survival benefit of eribulin mesylate in comparison with taxane regimens for metastatic cancer patients
|
Kikuchi, Y.
|
|
|
27 |
S9 |
p. ix40
|
artikel
|
| 70 |
346P An estimation of the population survival benefit of first-course chemotherapy and immunotherapy for leukemia
|
Do, V.
|
|
|
27 |
S9 |
p. ix108
|
artikel
|
| 71 |
163P An evaluation of the anti-cancerous potential of 5-epi- sinuleptolide in pancreatic cancer
|
Kuo, Y.H.
|
|
|
27 |
S9 |
p. ix50-ix51
|
artikel
|
| 72 |
345P A new L-asparaginase as a promising biodrug to acute lymphoblastic leukemia treatment
|
Schultz, L.
|
|
|
27 |
S9 |
p. ix108
|
artikel
|
| 73 |
560P A next-generation sequencing analysis indicates genomic alterations in pathological morphologies: A genomic case report of pulmonary carcinosarcoma harbouring EGFR mutation
|
Koba, G.
|
|
|
27 |
S9 |
p. ix182
|
artikel
|
| 74 |
424P An IOS app based differentiation of benign vs malignant ovarian mass applying International Ovarian Tumour Analysis(IOTA) sonographic features - A pictorial assay
|
Thiraviyam, I.
|
|
|
27 |
S9 |
p. ix133
|
artikel
|
| 75 |
527P An observational study of quality of life in Thai colorectal cancer patients who received chemotherapy
|
Chansriwong, P.
|
|
|
27 |
S9 |
p. ix171
|
artikel
|
| 76 |
520P Anti-angiogenic agents in combination with chemotherapy in first-line treatment of small cell lung cancer: A systematic review and meta-analysis
|
Wen, L.
|
|
|
27 |
S9 |
p. ix169
|
artikel
|
| 77 |
159P Antioxidant effect of mangiferin: The potential anti-cancer therapeutic agent
|
Roy, R.
|
|
|
27 |
S9 |
p. ix49-ix50
|
artikel
|
| 78 |
318P Antiproliferative effect of Moringaoleifera root extract on ovarian carcinoma: An in vitro study
|
Ghosh, A.
|
|
|
27 |
S9 |
p. ix99
|
artikel
|
| 79 |
9P Anti-tumor effects mediated by the activation of natural cytotoxicity receptors of natural killer cells
|
Kim, H.Y.
|
|
|
27 |
S9 |
p. ix3
|
artikel
|
| 80 |
3P Anti-VEGF and integrin-linked kinase knockdown inhibit angiogenesis in vitro and suppress vascular tumor growth in vivo
|
Mabeta, P.
|
|
|
27 |
S9 |
p. ix1
|
artikel
|
| 81 |
464P Apatinib (YN968D1) in performance status 2 or 3 patients with EGFR wild-type metastatic non-small cell lung cancer (NSCLC): A single-arm phase II study
|
Ya, Z.C.
|
|
|
27 |
S9 |
p. ix149
|
artikel
|
| 82 |
193P A phase 1 study evaluating the pharmacokinetics (PK), safety, and efficacy of regorafenib (REG) in Chinese patients with advanced, refractory solid tumors
|
Cao, J.
|
|
|
27 |
S9 |
p. ix60
|
artikel
|
| 83 |
583P A prospective observational study to see the effect of pelvic radiation on hematopoetic system
|
Sharmin, S.
|
|
|
27 |
S9 |
p. ix189
|
artikel
|
| 84 |
103P A prospective study on 70 patients with neo-adjuvant chemotherapy in locally advanced breast cancer (LABC)
|
Sumon, M.A.
|
|
|
27 |
S9 |
p. ix31
|
artikel
|
| 85 |
488P A retrospective audit on usage of oral water soluble contrast in patients with known advanced cancer
|
Heng, S.
|
|
|
27 |
S9 |
p. ix158
|
artikel
|
| 86 |
118P A retrospective comparison of eribulin and capecitabine in patients with HER2-negative metastatic breast cancer
|
Tsushita, N.
|
|
|
27 |
S9 |
p. ix35-ix36
|
artikel
|
| 87 |
349P A retrospective multicenter survey of hepatitis B virus infection (HBV) screening and HBV-DNA monitoring in patients receiving hematopoietic stem cell transplantation and rituximab-based chemotherapy
|
Nakashima, T.
|
|
|
27 |
S9 |
p. ix109
|
artikel
|
| 88 |
578P A retrospective observational study of efficacy and safety of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with solid tumours
|
Bhatt, A.D.
|
|
|
27 |
S9 |
p. ix188
|
artikel
|
| 89 |
80P A retrospective review of breast cancer care in North Okkalapa Hospital, Yangon, Myanmar
|
Sein, N.
|
|
|
27 |
S9 |
p. ix23-ix24
|
artikel
|
| 90 |
537P A retrospective study on analgesic requirements for thoracoscopic surgery postoperative pain
|
Mizuno, H.
|
|
|
27 |
S9 |
p. ix174
|
artikel
|
| 91 |
545P A retrospective study on prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small cell carcinoma of the esophagus
|
Wang, Y.
|
|
|
27 |
S9 |
p. ix177
|
artikel
|
| 92 |
526P A retrospective study on the protective effect of nonsteroidal anti-inflammatory drugs on panitumumab-related skin symptoms
|
Ishikawa, H.
|
|
|
27 |
S9 |
p. ix171
|
artikel
|
| 93 |
229P A single arm, multicenter, phase II trial of oxaliplatin plus capecitabine in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)
|
Tianshu, L.
|
|
|
27 |
S9 |
p. ix72
|
artikel
|
| 94 |
387P A single center retrospective paired study in west china hospital: cetuximab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma
|
Li, P.
|
|
|
27 |
S9 |
p. ix120
|
artikel
|
| 95 |
107P Assessment of correlation between polymorphism of leptin gene promoter (LEP G2548) with its serum levels in patients and controls
|
Fard, Z. Tahmasebi
|
|
|
27 |
S9 |
p. ix32
|
artikel
|
| 96 |
126P Assessment of EpCAM Intensity of Expression and Outcome in breast Carcinoma Neoadjuvant Chemotherapy Treated Patients
|
Shalaby, A.M.R.
|
|
|
27 |
S9 |
p. ix38
|
artikel
|
| 97 |
347P Association between allergic conditions and risk of non- Hodgkin lymphoma and Hodgkin lymphoma: A systematic review and meta-analysis
|
Yang, J.
|
|
|
27 |
S9 |
p. ix108
|
artikel
|
| 98 |
251P Association of Epstein-Barr virus with prognosis of patients with esophageal squamous cell carcinoma: A retrospective cohort study
|
Shahidsales, S.
|
|
|
27 |
S9 |
p. ix78-ix79
|
artikel
|
| 99 |
338P Association of kynurenine, tryptophan and key enzymes involved in kynurenine pathway of tryptophan catabolism with Imatinib duration in patients with chronic myeloid leukemia
|
Mohania, D.
|
|
|
27 |
S9 |
p. ix106
|
artikel
|
| 100 |
557P Association of TGFB1 exon 1 129 T/C polymorphism with reduced risk of sporadic breast cancer in older North Indian women population
|
Pal, R.
|
|
|
27 |
S9 |
p. ix181
|
artikel
|
| 101 |
422P A study on the correlation between body composition and durability of chemotherapy; A prospective cohort study
|
Ji, J.H.
|
|
|
27 |
S9 |
p. ix132
|
artikel
|
| 102 |
423P A targeted cancer clinical sequencing system based on a clinical biobank in Hokkaido University Hospital
|
Nishihara, H.
|
|
|
27 |
S9 |
p. ix132-ix133
|
artikel
|
| 103 |
204P Attenuated MMR and CIN pathway promote CRC progression through CDC25A upregulation: role of DNMT inhibitors
|
Banerjee, K.
|
|
|
27 |
S9 |
p. ix63
|
artikel
|
| 104 |
417P Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)
|
Chan, B.A.
|
|
|
27 |
S9 |
p. ix130
|
artikel
|
| 105 |
93P Awareness of breast cancer among surgical female inpatients in Kedah
|
Kirubakaran, R.
|
|
|
27 |
S9 |
p. ix27
|
artikel
|
| 106 |
465P 5-aza-2'-deoxycytidine enhances chemo sensitivity to cisplatin by up-regulating miRNA-320a in lung adenocarcinoma cells harboring wild-type EGFR
|
Wu, F.
|
|
|
27 |
S9 |
p. ix149
|
artikel
|
| 107 |
471P Baseline full blood count parameters as predictors of response to PD-1 inhibition in advanced NSCLC
|
Crumbaker, M.
|
|
|
27 |
S9 |
p. ix151
|
artikel
|
| 108 |
344P B cell precursor acute lymphoblastic leukemia (ALL) shows similar drug response in pdx mice and the corresponding patient
|
Wang, Z.
|
|
|
27 |
S9 |
p. ix107
|
artikel
|
| 109 |
270P Benzyl-isothiocyanate induces apoptosis and inhibits migration and invasion of hepatocellular carcinoma cells in vitro
|
Li, M.
|
|
|
27 |
S9 |
p. ix83-ix84
|
artikel
|
| 110 |
186P Bevacizumab in combination with 5-fluorouracil (5-FU) based doublet chemotherapy as neoadjuvant therapy for Chinese patients with previously untreated, unresectable liver-only metastatic colorectal cancer: A multi-center, single-arm phase II study
|
Wan, D.-S.
|
|
|
27 |
S9 |
p. ix58
|
artikel
|
| 111 |
314P Bevacizumab in ovarian cancer: Experience in a tertiary hospital of northern Taiwan
|
Chen, W.-C.
|
|
|
27 |
S9 |
p. ix98
|
artikel
|
| 112 |
326P Biomarker discovery for early prediction of therapy resistance in cervical cancers
|
Choo, B.A.
|
|
|
27 |
S9 |
p. ix101-ix102
|
artikel
|
| 113 |
457P Bisphosphonates enhance effect of EGFR-TKIs in NSCLC patients with EGFR mutation and bone metastases
|
Jiang, T.
|
|
|
27 |
S9 |
p. ix147
|
artikel
|
| 114 |
311P Blockade of vascular endothelial growth factor receptors by tivozanib inhibits growth and restores chemosensitivity in human ovarian carcinoma cells
|
Zarrinrad, G.
|
|
|
27 |
S9 |
p. ix97-ix98
|
artikel
|
| 115 |
399P Blocking CD47 and autophagy for the therapy of non-small-cell lung cancer
|
Zhang, X.
|
|
|
27 |
S9 |
p. ix124
|
artikel
|
| 116 |
538P Blood cultures in febrile neutropenic patients with cancer
|
Novin, K.
|
|
|
27 |
S9 |
p. ix174-ix175
|
artikel
|
| 117 |
111P BMI effect prognostic features of breast cancer treatments
|
Hojouj, M.I.
|
|
|
27 |
S9 |
p. ix33
|
artikel
|
| 118 |
215P 53BP1 loss induces the chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting ATM-CHK2-P53 pathway
|
Ma, H.
|
|
|
27 |
S9 |
p. ix66
|
artikel
|
| 119 |
83P Breast cancer management in an Indian oncology framework: Comparison with the standard guidelines
|
Sharma, A.
|
|
|
27 |
S9 |
p. ix24
|
artikel
|
| 120 |
81P Breast Self-Examination (BSE): A strategy for early detection of breast cancer in Nigeria
|
Adetule, Y.C.
|
|
|
27 |
S9 |
p. ix24
|
artikel
|
| 121 |
131P Breast-specific gamma imaging (BSGI) as follow-up after breast cancer surgery: Comparison with ultrasound and mammography
|
Yi, S.Y.
|
|
|
27 |
S9 |
p. ix39
|
artikel
|
| 122 |
409P CARAMEL study: ClinicAl prognostic biomarkers for Ipilimumab-Related outcome in metastatic MELanoma patients
|
Orgiano, L.
|
|
|
27 |
S9 |
p. ix127
|
artikel
|
| 123 |
97P Cardiac arrhythmia is highly associated with breast cancer compared to benign breast disease
|
Jung, S.P.
|
|
|
27 |
S9 |
p. ix28
|
artikel
|
| 124 |
582P Cardioprotective effects of pentoxifylline on ventricular fibrillation and fibrosis in rat model of radiation-induced heart abnormalities
|
Safaie, A.M.
|
|
|
27 |
S9 |
p. ix8
|
artikel
|
| 125 |
572P Cardiotoxicity in Chinese cancer patients treated with 5- fluorouracil or capecitabine: A multicenter prospective observational study
|
Chen, G.
|
|
|
27 |
S9 |
p. ix186
|
artikel
|
| 126 |
288P Castration-resistant prostate cancer: Results of chemotherapy treatment in the real life practice
|
Bandidwattanawong, C.
|
|
|
27 |
S9 |
p. ix91
|
artikel
|
| 127 |
8P Cdk4/6 inhibitor activity in metastatic bladder cancer cell lines is independently of RB1 status
|
Castellano, D.
|
|
|
27 |
S9 |
p. ix3
|
artikel
|
| 128 |
175P CEA clearance pattern is a strong predictor of pathologic complete response after neoadjuvant chemoradiation for rectal cancer: validation of FOWARC trial
|
Hu, H.
|
|
|
27 |
S9 |
p. ix55
|
artikel
|
| 129 |
73P Change in the bone absorption marker levels in aromatase inhibitor-treated patients who were switched from oral bisphosphonates to denosumab
|
Mizuno, Y.
|
|
|
27 |
S9 |
p. ix22
|
artikel
|
| 130 |
196P Changes in serum p53 antibody levels around the time of surgery and p53 mutations predict the prognosis of colorectal cancer
|
Satoyoshi, T.
|
|
|
27 |
S9 |
p. ix61
|
artikel
|
| 131 |
536P Characteristics and outcome of cancer patients with sepsis requiring admission to the intensive care unit
|
Sunggoro, A.J.
|
|
|
27 |
S9 |
p. ix174
|
artikel
|
| 132 |
59P Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN IHC as a means for sample quality screening
|
Zhang, X.-C.
|
|
|
27 |
S9 |
p. ix17
|
artikel
|
| 133 |
113P Chemotherapy administration safety standards for preventing medication errors and adverse drug reactions in patients with breast cancers
|
Pakdel, A. Fani
|
|
|
27 |
S9 |
p. ix33
|
artikel
|
| 134 |
319P Choriocarcinoma: A 10 year tertiary care cancer hospital experience
|
Yasmeen, S.
|
|
|
27 |
S9 |
p. ix99-ix100
|
artikel
|
| 135 |
339P Chronic myeloid leukemia: diagnosis, management and treatment options in Moldova
|
Musteata, V.
|
|
|
27 |
S9 |
p. ix106
|
artikel
|
| 136 |
250P Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer
|
Chen, J.
|
|
|
27 |
S9 |
p. ix78
|
artikel
|
| 137 |
366P Circulating microRNAs as novel promising biomarkers for early detection of tongue cancer
|
Tahara, H.
|
|
|
27 |
S9 |
p. ix114
|
artikel
|
| 138 |
54P Circulating prostate-specific antigen and telomere length in a nationally representative sample of men without history of prostate cancer
|
Wulaningsih, W.
|
|
|
27 |
S9 |
p. ix15-ix16
|
artikel
|
| 139 |
199P Circulating tumor DNA as a dynamic marker for disease burden in patients with metastatic colorectal cancer
|
Hsu, A.
|
|
|
27 |
S9 |
p. ix62
|
artikel
|
| 140 |
69P Cisplatin based preoperative chemotherapy regimens for basal-like breast cancer potentially improve prognosis even in patients without pCR: A retrospective analysis from a single-institution
|
Yamaguchi, A.
|
|
|
27 |
S9 |
p. ix21
|
artikel
|
| 141 |
273P Cisplatin in combination with pemetrexed in the treatment of patients for advanced malignant peritoneal mesothelioma: Retrospective study of 21 cases
|
Shingo, K.
|
|
|
27 |
S9 |
p. ix84
|
artikel
|
| 142 |
212P Claudin-2: a new regulator of cancer stem cell self-renewal in colorectal cancer
|
Paquet-Fifield, S.
|
|
|
27 |
S9 |
p. ix65
|
artikel
|
| 143 |
475P Clinical characteristics and current management of non-small cell lung cancer patients aged more than 65 years old in Thailand: A single institute experience
|
Sintawichai, N.
|
|
|
27 |
S9 |
p. ix152
|
artikel
|
| 144 |
84P Clinical characteristics and outcomes of bilateral breast cancer in a Tunisian cohort
|
Jmour, O.
|
|
|
27 |
S9 |
p. ix24-ix25
|
artikel
|
| 145 |
85P Clinical characteristics and outcomes of synchronous bilateral breast cancer in a Tunisian cohort
|
Jmour, O.
|
|
|
27 |
S9 |
p. ix25
|
artikel
|
| 146 |
321P Clinical course comparison between patients with type 1 and type 2 uterine endometrial cancers
|
Takehara, Y.
|
|
|
27 |
S9 |
p. ix100
|
artikel
|
| 147 |
51P Clinical feasibility of EGFR mutation detection by CastPCR in plasma cell-free DNA of lung adenocarcinoma patients
|
Yang, Y.
|
|
|
27 |
S9 |
p. ix15
|
artikel
|
| 148 |
474P Clinical features of intradural extramedullary spinal cord metastases in primary lung cancer
|
Xu, Y.
|
|
|
27 |
S9 |
p. ix152
|
artikel
|
| 149 |
36P Clinical impact and carcinogenic mechanism of USP3 overexpression in gastric cancer
|
Lin, K.-Y.
|
|
|
27 |
S9 |
p. ix11
|
artikel
|
| 150 |
180P Clinical outcome of anal squamous cell carcinoma treated with chemoradiotherapy with 5-fluorouracil plus mitomycin C
|
Doi, A.
|
|
|
27 |
S9 |
p. ix56-ix57
|
artikel
|
| 151 |
284P Clinical outcome of the treatment for residual masses after chemotherapy for metastatic germ cell tumors
|
Jikuya, R.
|
|
|
27 |
S9 |
p. ix88
|
artikel
|
| 152 |
275P Clinical outcomes of second transurethral resection in nonmuscle invasive high grade bladder cancer: a retrospective, multi-institutional, collaborative study
|
Kamiya, N.
|
|
|
27 |
S9 |
p. ix86
|
artikel
|
| 153 |
469P Clinical outcome study of crizotinib in IHC proven EML4-ALK fusion gene among Indian patients with adenocarcinoma lung
|
Batra, U.
|
|
|
27 |
S9 |
p. ix150
|
artikel
|
| 154 |
263P Clinical sequencing system for pancreatic cancer as a laboratory examination
|
Hayashi, H.
|
|
|
27 |
S9 |
p. ix82
|
artikel
|
| 155 |
515P Clinical significance of bone marrow chromosomal analysis in rhabdomyosarcoma
|
Lee, D.
|
|
|
27 |
S9 |
p. ix167
|
artikel
|
| 156 |
184P Clinical significance of discordance between carcinoembryonic antigen levels and RECIST in metastatic colorectal cancer
|
Kim, I.-H.
|
|
|
27 |
S9 |
p. ix57-ix58
|
artikel
|
| 157 |
35P Clinical significance of expression of cripto-1 in patients of squamous cell carcinoma of oropharynx
|
Kumar, M.S.
|
|
|
27 |
S9 |
p. ix10-ix11
|
artikel
|
| 158 |
74P Clinical translation of serum microRNA 21 as a potential prognostic marker in breast cancer patients and predictive marker of radiotherapy
|
Moslemi, D.
|
|
|
27 |
S9 |
p. ix22
|
artikel
|
| 159 |
154P Clinical trial designs for the approval of rare cancer drugs in Japan
|
Noguchi, E.
|
|
|
27 |
S9 |
p. ix48
|
artikel
|
| 160 |
282P Clinico-pathological characteristics and outcome in recurrent renal cell carcinoma
|
Tiwari, P.
|
|
|
27 |
S9 |
p. ix88
|
artikel
|
| 161 |
425P Clinicopathological factorsassociatedwith postoperative survival in patients undergoing lobectomy with pathological stage IB non-small-cell lung cancer
|
Shimomura, M.
|
|
|
27 |
S9 |
p. ix134
|
artikel
|
| 162 |
351P Clinico-pathologic profile and clinical outcomes of patients with indolent lymphoma at the Cancer Institute of the Philippine General Hospital: A 7-year experience
|
Dela Rosa, P.R.
|
|
|
27 |
S9 |
p. ix109-ix110
|
artikel
|
| 163 |
88P Color Doppler parameters: a non invasive prognostic marker in carcinoma breast in both naive and neoadjuvant chemotherapy patients.
|
Govardhan, H.B.
|
|
|
27 |
S9 |
p. ix26
|
artikel
|
| 164 |
192P Colorectal cancer care in Yangon General Hospital
|
Maw, H.H.
|
|
|
27 |
S9 |
p. ix60
|
artikel
|
| 165 |
264P Combined chemoradiotherapy in patients with locally advanced pancreatic cancer
|
Ivanova, A.
|
|
|
27 |
S9 |
p. ix82
|
artikel
|
| 166 |
426P Combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas
|
Kuroda, H.
|
|
|
27 |
S9 |
p. ix134
|
artikel
|
| 167 |
400P Combining anti-angiogenesis and immunotherapy enhances antitumor effect in lung cancer
|
Zhao, S.
|
|
|
27 |
S9 |
p. ix124
|
artikel
|
| 168 |
236P Comparing chemo-radiotherapy with 5-fluorouracil and cisplatin versus thoracoscopic esophagectomy for cStage II- III esophageal squamous cell carcinoma
|
Kashiwada, T.
|
|
|
27 |
S9 |
p. ix74
|
artikel
|
| 169 |
114P Comparison of conventional and hypo fractionation radiation schedule on pulmonary function test in carcinoma of the breast as an acute effect
|
Ibrahim A, K.
|
|
|
27 |
S9 |
p. ix34
|
artikel
|
| 170 |
430P Comparison of multimodality therapy in clinical stage IIIAN2 non-small cell lung cancer: consecutive analysis of surgery, radiotherapy, chemotherapy and their combination
|
Katsuya, Y.
|
|
|
27 |
S9 |
p. ix136
|
artikel
|
| 171 |
459P Comparison of predictive value between metabolic tumor volume and RECIST 1.1 assessed by 18F-FDG PET-CT in patients with lung cancer
|
Lin, J.-T.
|
|
|
27 |
S9 |
p. ix147
|
artikel
|
| 172 |
125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab
|
Veenstra, C.
|
|
|
27 |
S9 |
p. ix37
|
artikel
|
| 173 |
206P Comprehensive genomic research to clarify the mechanism of drug resistance in colon cancer
|
Tanaka, T.
|
|
|
27 |
S9 |
p. ix64
|
artikel
|
| 174 |
108P COMT, APOE, and BDNF gene polymorphisms modulate chemotherapy-induced cognitive impairment in breast cancer survivors
|
Li, W.
|
|
|
27 |
S9 |
p. ix32
|
artikel
|
| 175 |
379P Concurrent chemoradiotherapy with daily low-dose carboplatin for early laryngeal cancers (T1b/T2): A retrospective analysis
|
Wakasugi, T.
|
|
|
27 |
S9 |
p. ix117-ix118
|
artikel
|
| 176 |
584P Controlled release of anti-cancer flutamide-related escape products under exposure to magnetic fields
|
Nakagawa, H.
|
|
|
27 |
S9 |
p. ix189
|
artikel
|
| 177 |
30P Correlation between Ki-67 expression and clinic-pathological features of soft tissue sarcomas in the extremities
|
Kelany, M.
|
|
|
27 |
S9 |
p. ix9
|
artikel
|
| 178 |
315P Correlation between the expression of heat shock proteins and the prognosis of advanced ovarian serous adenocarcinoma
|
Zuo, J.
|
|
|
27 |
S9 |
p. ix98-ix99
|
artikel
|
| 179 |
55P CTC count & gene expression profiling among Filipino NSCLC
|
Luna, H.G.
|
|
|
27 |
S9 |
p. ix15-ix16
|
artikel
|
| 180 |
19P Curcumin oleoresin inhibits cell growth and migratory properties of breast cancer cells through inhibition of NF-kB pathway
|
Avan, A.
|
|
|
27 |
S9 |
p. ix5-ix6
|
artikel
|
| 181 |
122P CXCL-12 is a potential marker to predict risk of lymph node metastasis in infiltrating duct carcinoma
|
Heriyanto, D.S.
|
|
|
27 |
S9 |
p. ix37
|
artikel
|
| 182 |
340P Cytogenetic and molecular response rates in AYA CML CP patients on imatinib based on the baseline BMI
|
Ganta, R.R.
|
|
|
27 |
S9 |
p. ix106
|
artikel
|
| 183 |
174PD A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare)
|
Zhang, T.
|
|
|
27 |
S9 |
p. ix54-ix55
|
artikel
|
| 184 |
445PD ASCEND-6: single-arm, open label, multicenter phase 1/2 study of ceritinib in Chinese pts with advanced ALK- rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with crizotinib
|
Zhang, L.
|
|
|
27 |
S9 |
p. ix143
|
artikel
|
| 185 |
523PD Assessing the effectiveness of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy
|
Mehra, N.J.
|
|
|
27 |
S9 |
p. ix170
|
artikel
|
| 186 |
499PD Assessment of distress (depression, anxiety and stress) in Indian women with breast cancer: Predictive role of spiritual well being
|
Srivastava, J.
|
|
|
27 |
S9 |
p. ix161-ix162
|
artikel
|
| 187 |
448PD Association between EGFR T790M status and progression patterns during initial EGFR-TKIs treatment in patients harboring EGFR mutation
|
Oya, Y.
|
|
|
27 |
S9 |
p. ix144
|
artikel
|
| 188 |
141PD Bacoside A induced Sub-G0 arrest and early apoptosis in human glioblastomacelllineU-87MGthrough notch signaling pathway
|
Aithal, M.G.S.
|
|
|
27 |
S9 |
p. ix43
|
artikel
|
| 189 |
68PD BRCA1/2 mutation analysis in Indonesian hereditary breast
|
Haryono, S.
|
|
|
27 |
S9 |
p. ix20
|
artikel
|
| 190 |
1PD Breast cancer blood-derived exosomes: Characterisation of protein composition in search for new biomarkers
|
Tutanov, O.S.
|
|
|
27 |
S9 |
p. ix1
|
artikel
|
| 191 |
524PD Cefepime versus cefoperazone/sulbactum plus amikacin as empirical antibiotic therapy in cancer patients with febrile neutropenia
|
Madasamy, P.
|
|
|
27 |
S9 |
p. ix170
|
artikel
|
| 192 |
308PD Cervical cancer burden in the Radiation Oncology Unit, Mandalay General Hospital
|
Myint, A.A.
|
|
|
27 |
S9 |
p. ix97
|
artikel
|
| 193 |
507PD Clinical presentation, treatment, outcome, and prognostic factors of non-metastatic Ewing sarcoma family of tumors: A single centre experience of 35 patients
|
Khosla, D.
|
|
|
27 |
S9 |
p. ix165
|
artikel
|
| 194 |
525PD Clinical profile of anemia and micronutrient deficiency in Acute Lymphoblastic Leukemia patients on maintenance therapy
|
Pattnaik, J.
|
|
|
27 |
S9 |
p. ix171
|
artikel
|
| 195 |
305PD Clinical profile of germ cell tumor of ovary - A single centreexperience
|
Ganguly, S.
|
|
|
27 |
S9 |
p. ix96
|
artikel
|
| 196 |
363PD Community based screening for early detection of head and neck cancer among tribal community in Wayanad District, India
|
Palliyal, S.
|
|
|
27 |
S9 |
p. ix113-ix114
|
artikel
|
| 197 |
66PD Comparison of blue dye and radio-tracer markers for identification of axillary sentinel node in patients with early breast cancer
|
Loza, P.
|
|
|
27 |
S9 |
p. ix20
|
artikel
|
| 198 |
144PD Cranio-Spinal irradiation - is acute hematological toxicity
|
Thakur, P.
|
|
|
27 |
S9 |
p. ix43-ix44
|
artikel
|
| 199 |
362PD Development and validation of a nomogram to predict the probability of recurrence in patients with major salivary gland cancers
|
Hung, C.-Y.
|
|
|
27 |
S9 |
p. ix113
|
artikel
|
| 200 |
29PD Downregulation of FBP1 promotes tumor metastasis and indicates poor prognosis in gastric cancer via regulating epithelial-mesenchymal transition
|
Li, J.
|
|
|
27 |
S9 |
p. ix9
|
artikel
|
| 201 |
490P Decisions made by surrogates for patients versus oneself in an irreversible coma: A study to determine the importance of advance directives in the event of an irreversible coma
|
Samarasekara, K.
|
|
|
27 |
S9 |
p. ix159
|
artikel
|
| 202 |
489P Decrease in Palliative Performance Scale score during 1 week predicts survival in advanced cancer patients
|
Yoon, S.
|
|
|
27 |
S9 |
p. ix158-ix159
|
artikel
|
| 203 |
221PD Efficacy and safety of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02, BAX-2398) in patients with metastatic pancreatic cancer in Asia: A subgroup analysis of the phase 3 NAPOLI-1 Study
|
Chen, L.-T.
|
|
|
27 |
S9 |
p. ix69-ix70
|
artikel
|
| 204 |
222PD Efficacy of consolidation chemotherapy for clinicalresponder to concurrent chemoradiation in stage II-III squamous cancer of the esophagus
|
Chen, Y.
|
|
|
27 |
S9 |
p. ix70
|
artikel
|
| 205 |
505PD Elevated blood neutrophil-to-lymphocyte ratio is associated with poor clinical outcome in patients with synovial sarcoma
|
Zhou, L.
|
|
|
27 |
S9 |
p. ix164
|
artikel
|
| 206 |
509P Desmoid-type fibromatosis with a remarkable response to pazopanib treatment
|
Kobayashi, E.
|
|
|
27 |
S9 |
p. ix165
|
artikel
|
| 207 |
402P Detailed clinical course of immune-related hepatotoxicity in advanced melanoma patients using immune checkpoint inhibitors
|
Maruki, Y.
|
|
|
27 |
S9 |
p. ix125
|
artikel
|
| 208 |
370P Determination of bioimpedance in oral potentially malignant disorders
|
Sarode, G.S.
|
|
|
27 |
S9 |
p. ix115
|
artikel
|
| 209 |
372P Determination of expression of EGFR in premalignant and malignant lesions of the oral cavity and evaluating the role of Gefitinib in EGFR positive lesions
|
Velu, U.
|
|
|
27 |
S9 |
p. ix116
|
artikel
|
| 210 |
435P Development of PF-06439535, a potential biosimilar to bevacizumab
|
Jacobs, I.A.
|
|
|
27 |
S9 |
p. ix138
|
artikel
|
| 211 |
506PD Ewing Sarcoma family tumors of vertebral column treated with uniform chemotherapy protocols: Experience from a tertiary cancer care center
|
Kumar, A.
|
|
|
27 |
S9 |
p. ix164-ix165
|
artikel
|
| 212 |
309PD Features of cervical cancer in HIV-infected and uninfected women in association with human papilloma virus
|
Tashmetov, M.N.
|
|
|
27 |
S9 |
p. ix97
|
artikel
|
| 213 |
172PD Final analysis: Phase II trial of irinotecan/S-1/cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type metastatic colorectal cancer: HGCSG0902. Comparison of administration interval in cetuximab treatment
|
Ando, T.
|
|
|
27 |
S9 |
p. ix54
|
artikel
|
| 214 |
303PD Genetic characterization of ovarian carcinoma patients in Taiwan
|
Chen, C.J.
|
|
|
27 |
S9 |
p. ix95-ix96
|
artikel
|
| 215 |
364PD Head & neck cancer pharmacogenetics: case control study on 5- fluorouracil and cisplatin adjuvant treatment outcome
|
Bhatia, S.S.Y.
|
|
|
27 |
S9 |
p. ix114
|
artikel
|
| 216 |
225PD HER 2 over-expression in patients with esophageal squamous cell carcinoma: Correlation with response to neoadjuvant chemoradiation and survival
|
Mashhad, M. Joudi
|
|
|
27 |
S9 |
p. ix71
|
artikel
|
| 217 |
504PD High neutrophil-lymphocyte ratio is an independent indicator of poor prognosis in high grade undifferentiated pleomorphic sarcoma
|
Chew, W.H.W.
|
|
|
27 |
S9 |
p. ix164
|
artikel
|
| 218 |
28PD HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer via epithelial-mesenchymal transition
|
Cheng, N.
|
|
|
27 |
S9 |
p. ix9
|
artikel
|
| 219 |
143PD Hypofractionated radiotherapy combined with temozolomide for large brain metastases: A prospective trial
|
Ma, Y.
|
|
|
27 |
S9 |
p. ix43
|
artikel
|
| 220 |
421P Diagnosis of right upper lobar lymph node metastasis by modified TLG
|
Dejima, H.
|
|
|
27 |
S9 |
p. ix132
|
artikel
|
| 221 |
200P Diagnostic accuracy of Raman spectroscopy for malignant and benign colorectal lesions: A meta-analysis
|
Tie, Y.
|
|
|
27 |
S9 |
p. ix62
|
artikel
|
| 222 |
559P Differential association of TGF-β expression with MCP-1 and RANTES expression in primary tumor depending on stages of breast cancer patients from Eastern India
|
Mandal, G.
|
|
|
27 |
S9 |
p. ix181-ix182
|
artikel
|
| 223 |
495P Difficulties in providing palliative care in rural India (West Bengal) - experience of an NGO
|
Manna, A.
|
|
|
27 |
S9 |
p. ix160
|
artikel
|
| 224 |
396PD IL-2 synergizes with PD-1/PD-L1 blockade via CD28/CHK1 pathway to enhance CD81 T cell responses in lung squamous cell carcinoma
|
Huang, S.-M.
|
|
|
27 |
S9 |
p. ix123
|
artikel
|
| 225 |
161P Discovery of novel 1,3,5-triazine-thiourea based dual PI3K/ mTOR inhibitor against Non-small cell lung cancer (NSCLC)
|
Singh, U.P.
|
|
|
27 |
S9 |
p. ix50
|
artikel
|
| 226 |
452P Disease progression site and subsequent therapy after progression during alectinib therapy
|
Murakami, H.
|
|
|
27 |
S9 |
p. ix145-ix146
|
artikel
|
| 227 |
316P Disruption of DNA double strand break repair by VCP inhibition in ovarian and pancreatic cancer
|
Astuti, Y.
|
|
|
27 |
S9 |
p. ix99
|
artikel
|
| 228 |
477P Distinctive impact of whole-body metastases on the survival outcomes according to the histological subtypes in advanced non-small cell lung cancer
|
Lee, D.S.
|
|
|
27 |
S9 |
p. ix153
|
artikel
|
| 229 |
397PD KRAS mutation-induced upregulation of PD-L1 mediates immune escape in lung adenocarcinoma
|
Hong, S.
|
|
|
27 |
S9 |
p. ix123
|
artikel
|
| 230 |
450PD Leptomeningeal metastases in non-small cell lung cancer
|
Li, Y.-S.
|
|
|
27 |
S9 |
p. ix145
|
artikel
|
| 231 |
173PD MicroRNA MIR21, T cells, and PTGS2 expression in
|
Mima, K.
|
|
|
27 |
S9 |
p. ix54
|
artikel
|
| 232 |
447PD Modified ctDNA extraction method combined with blocker PCR assays improves the liquid biopsy efficiency in NSCLC patients
|
Zhang, M.
|
|
|
27 |
S9 |
p. ix144
|
artikel
|
| 233 |
223PD Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal cancer
|
Cheng, X.
|
|
|
27 |
S9 |
p. ix70
|
artikel
|
| 234 |
533P Docetaxel induced cutaneous toxicity in breast cancer patients
|
Das, C.K.
|
|
|
27 |
S9 |
p. ix173
|
artikel
|
| 235 |
513P Dose of doxorubicin and outcome for advanced or metastatic soft tissue sarcoma of non-extremities
|
Marshall, S.
|
|
|
27 |
S9 |
p. ix166
|
artikel
|
| 236 |
451PD Osimertinibat 80mg for refractoryleptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer
|
Hata, A.
|
|
|
27 |
S9 |
p. ix145
|
artikel
|
| 237 |
444PD Patient-reported outcomes (PROs) in ASCEND-5: A randomized, phase 3 study of ceritinib vs chemotherapy (CT) in patients (pts) with advanced anaplastic lymphoma kinase rearranged (ALK+) NSCLC previously treated with CT and crizotinib (CRZ)
|
Mok, T.S.K.
|
|
|
27 |
S9 |
p. ix142-ix143
|
artikel
|
| 238 |
306PD Patterns of care of cervical cancer in the elderly: A qualitative review of all published literature
|
Venkatesulu, B.P.
|
|
|
27 |
S9 |
p. ix96
|
artikel
|
| 239 |
398PD PD-L1 status in Taiwanese lung adenocarcinoma patients: Comparison of PD-L1 immunohistochemical assays using antibody clones 22C3, SP142 and SP263 with clinicopathological correlation
|
Yeh, Y.-C.
|
|
|
27 |
S9 |
p. ix123-ix124
|
artikel
|
| 240 |
224PD Predictors for recurrence after initial clinical complete response to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
|
Chao, Y.K.
|
|
|
27 |
S9 |
p. ix70-ix71
|
artikel
|
| 241 |
500PD_PR Influencing factors on chemotherapy-related cognitive impairment in patients with gastrointestinal cancer
|
Kim, J.H.
|
|
|
27 |
S9 |
p. ix162
|
artikel
|
| 242 |
498PD_PR Prevalence and types of distress among Adult and Young Adolescent (AYA) newly diagnosed with cancer in Singapore
|
Woldehaimanot, T.E.
|
|
|
27 |
S9 |
p. ix161
|
artikel
|
| 243 |
117PD_PR Survival benefit of surgical removal for the primary tumor in stage IV breast cancer patients
|
Kim, H.J.
|
|
|
27 |
S9 |
p. ix35
|
artikel
|
| 244 |
67PD Quality of life after risk-reducing salpingo-oophorectomy in BRCA carrier
|
Jang, Y.
|
|
|
27 |
S9 |
p. ix20
|
artikel
|
| 245 |
142PD Reirradiation for glioblastoma with temozolomide: Delicate balance between effectiveness and toxicity
|
Gupta, D.
|
|
|
27 |
S9 |
p. ix43
|
artikel
|
| 246 |
449PD Relative abundance of EGFR mutations predict tumor metastasis and EGFR-TKIs prognosis in patients with nonsmall cell lung cancer
|
Zhen, H.
|
|
|
27 |
S9 |
p. ix145
|
artikel
|
| 247 |
307PD Results of high dose rate interstitial- brachytherapy in the treatment of locally advanced carcinoma cervix: A single institution experience
|
Shamsundar, S.D.
|
|
|
27 |
S9 |
p. ix96
|
artikel
|
| 248 |
50P Droplet digital PCR measurement of c-Met gene amplification in plasma cell free DNA in patients with advanced NSCLC
|
Gao, H.-F.
|
|
|
27 |
S9 |
p. ix14
|
artikel
|
| 249 |
446PD Second-line afatinib vs erlotinib for patients with squamous cell carcinoma of the lung in LUX-Lung 8: analysis of tumor and serum biomarkers
|
Lee, K.H.
|
|
|
27 |
S9 |
p. ix143-ix144
|
artikel
|
| 250 |
65PD Significance of preoperative fine-needle aspiration biopsy for suspected cases of lymph node metastasis in primary breast cancer
|
Ogiya, A.
|
|
|
27 |
S9 |
p. ix20
|
artikel
|
| 251 |
302PD Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in endometrioid and clear cell ovarian cancer
|
Er, T.-K.
|
|
|
27 |
S9 |
p. ix95
|
artikel
|
| 252 |
365PD The role of Cox-2inhibitor in combination with chemoradiotherapy in head and neck carcinoma to reduce mucositis and other side effects
|
Mojahed, M.M.
|
|
|
27 |
S9 |
p. ix114
|
artikel
|
| 253 |
140PD The role of leptin and its receptor in oligo-astrocytic
|
Vokuda, R.S.
|
|
|
27 |
S9 |
p. ix42-ix43
|
artikel
|
| 254 |
304PD Treatment approach and prognosis of pediatric and adolescent non-epithelial malignant ovarian tumors: A retrospective prognosis analysis
|
Zhang, B.
|
|
|
27 |
S9 |
p. ix96
|
artikel
|
| 255 |
551PD Validation study to assess performance of IBM cognitive computing system Watson for oncology with Manipal multidisciplinary tumour board for 1000 consecutive cases: An Indian experience
|
Somashekhar S P, S.
|
|
|
27 |
S9 |
p. ix179
|
artikel
|
| 256 |
356P Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India
|
Gupta, V.G.
|
|
|
27 |
S9 |
p. ix111
|
artikel
|
| 257 |
70P “Early tumor shrinkage” might be a novel predictive factor relating to pCR in neoadjuvant chemotherapy for resectable breast cancer
|
Saiki, T.
|
|
|
27 |
S9 |
p. ix21
|
artikel
|
| 258 |
472P Effectiveness of nab-paclitaxel for malignant effusion in nonsmall cell lung cancer
|
Iwai, Y.
|
|
|
27 |
S9 |
p. ix151
|
artikel
|
| 259 |
40P Effect of ABCB1 and SLC22A16 genes polymorphism in outbreak of doxorubicin-based chemotherapy-induced grade 3/4 febrile neutropenia in Iranian breast cancer patients
|
Faraji, A.
|
|
|
27 |
S9 |
p. ix12
|
artikel
|
| 260 |
317P Effect of body mass index on survival in patients with epithelial ovarian cancer
|
Gohar, S.F.
|
|
|
27 |
S9 |
p. ix99
|
artikel
|
| 261 |
371P Effect of oral silymarin administration on prevention of radiotherapy induced mucositis: A randomized, double- blinded, placebo-controlled clinical trial
|
Hosseini, S.
|
|
|
27 |
S9 |
p. ix115-ix116
|
artikel
|
| 262 |
242P Effects of nal-IRI (MM-398) 6 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine based therapy: Results from NAPOLI-1
|
Hubner, R.
|
|
|
27 |
S9 |
p. ix76
|
artikel
|
| 263 |
412P Effects of statins on melanoma
|
Tran, K.B.
|
|
|
27 |
S9 |
p. ix128
|
artikel
|
| 264 |
156P Efficacy and safety of a novel nanosomal docetaxel lipid suspension (NDLS) as an anti cancer agent - a retrospective study
|
Ashraf, M.
|
|
|
27 |
S9 |
p. ix49
|
artikel
|
| 265 |
209P Efficacy and safety of SOX as an adjuvant therapy for stage 2/ 3 colon cancer in a group at high risk of recurrence in prospective study
|
Osawa, H.
|
|
|
27 |
S9 |
p. ix65
|
artikel
|
| 266 |
119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India
|
Sharma, A.
|
|
|
27 |
S9 |
p. ix36
|
artikel
|
| 267 |
238P Efficacy and toxicity of carboplatin/paclitaxel based chemoradiation for localized esophageal cancer
|
Qubtia, M.
|
|
|
27 |
S9 |
p. ix75
|
artikel
|
| 268 |
261P Efficacy of chemotherapy in patients with unresectable or metastatic pancreatic acinar cell carcinoma: Potentially improved efficacy with oxaliplatin-containing regimen
|
Cheon, J.
|
|
|
27 |
S9 |
p. ix81
|
artikel
|
| 269 |
227P Efficacy of conversional radical surgery following upfront docetaxel, oxalipaltin and S1 (DOS) regimen for advanced gastric cancer with a single non-curable factor
|
Wang, Y.
|
|
|
27 |
S9 |
p. ix71-ix72
|
artikel
|
| 270 |
454P Efficacy of crizotinib in NSCLC with concomitant ALK fusion and c-MET overexpression
|
Chen, R.-L.
|
|
|
27 |
S9 |
p. ix146
|
artikel
|
| 271 |
91P Efficacy of gabapentin for prevention of paclitaxel induced neuropathy: randomized double blind, phase 3 trial
|
Zare, M.
|
|
|
27 |
S9 |
p. ix26-ix27
|
artikel
|
| 272 |
194P Efficacy of second line chemotherapy following first line triplet chemotherapy in advanced colorectal cancer (ACRC)
|
Hakoun, A.M.
|
|
|
27 |
S9 |
p. ix61
|
artikel
|
| 273 |
10P Efficacy of tumor treating field therapy alone and in combination with doxorubicin in cellular model of breast cancer
|
Gharaee, N.
|
|
|
27 |
S9 |
p. ix3
|
artikel
|
| 274 |
286P Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistantprostate cancer(mCRPC):AnAsianmultinationalstudy
|
Ye, D.
|
|
|
27 |
S9 |
p. ix90
|
artikel
|
| 275 |
296P Efficiency of intermittent androgen blockade in patients with advanced prostate cancer
|
Tashmetov, M.N.
|
|
|
27 |
S9 |
p. ix93
|
artikel
|
| 276 |
478P EGFR mutation in NSCLC in Pakistan
|
Ahmed, Z.A.
|
|
|
27 |
S9 |
p. ix153
|
artikel
|
| 277 |
312P Elevated serum CA125 predicts recurrence in patients with completely resected ovarian clear cell carcinoma
|
Ebata, T.
|
|
|
27 |
S9 |
p. ix98
|
artikel
|
| 278 |
266P Elevation of neutrophil-to-lymphocyte ratio before first-line chemotherapy predicts a poor prognosis of second line chemotherapy in gastric cancer
|
Inoue, D.
|
|
|
27 |
S9 |
p. ix82-ix83
|
artikel
|
| 279 |
254P Elucidation of the mechanism of high-lymph node metastasis density in gastric cancer-H19-PEG10 axis
|
Ishii, S.
|
|
|
27 |
S9 |
p. ix79
|
artikel
|
| 280 |
401P Enhancing antitumor immunity by photodynamic therapy with gemcitabine in metastatic 4T1 breast tumor.
|
Agemy, L.
|
|
|
27 |
S9 |
p. ix124-ix125
|
artikel
|
| 281 |
436P Epidemiology and profile of non-small cell lung cancer (NSCLC) patients in Yangon General Hospital
|
Win, S.S.
|
|
|
27 |
S9 |
p. ix138
|
artikel
|
| 282 |
265P Epidemiology, outcome and prognostic factors of biliary tract cancer in the Tunisian population
|
Labidi, S.
|
|
|
27 |
S9 |
p. ix82
|
artikel
|
| 283 |
214P Establishment of colon cancer liver metastasis PDTX model for the evaluation of chemotherapy
|
Choi, S.
|
|
|
27 |
S9 |
p. ix66
|
artikel
|
| 284 |
24P Establishment of patient-derived xenografts from malignant pleural effusion using NOG mice
|
Chijiwa, T.
|
|
|
27 |
S9 |
p. ix7
|
artikel
|
| 285 |
492P Estimation of measure of pain and patient’s life quality with cancer of unknown primary focus associated with palliative chemotherapy
|
Beisenayeva, A.
|
|
|
27 |
S9 |
p. ix159
|
artikel
|
| 286 |
17P Ethanol extract of Lophatheri Herba exhibits in vitro and in vivo anti-metastatic and anti-angiogenic activities in malignant cancer cells
|
Kim, A.
|
|
|
27 |
S9 |
p. ix5
|
artikel
|
| 287 |
386P Expectations and preferences for palliative chemotherapy in head and neck cancers patients
|
Patil, V.M.
|
|
|
27 |
S9 |
p. ix120
|
artikel
|
| 288 |
529P Exploratory study for preventing nausea and vomiting by switching from pranisetron + dexamethasone (Days 1-3) + aprepitant (Days 1-3) to palonosetron + pexamethasone (Day 1) in patients undergoing moderatelyemetogenic chemotherapy
|
Kimura, T.
|
|
|
27 |
S9 |
p. ix172
|
artikel
|
| 289 |
52P Expression of CT antigens in periampullary carcinomas patients: Potential minimally-invasive biomarkers for diagnosis
|
Singh, S.
|
|
|
27 |
S9 |
p. ix15
|
artikel
|
| 290 |
418P Expression of mTOR pathway components in gastric neuroendocrine neoplasms
|
Peregorodiev, I.
|
|
|
27 |
S9 |
p. ix131
|
artikel
|
| 291 |
60P Expression of PD-L1 is associated with poor prognosis in breast cancer: A meta-analysis
|
Zhang, M.
|
|
|
27 |
S9 |
p. ix17
|
artikel
|
| 292 |
252P Expression of Ribophorine II (RPN2) is a new prognostic factor in human gastric adenocarcinoma
|
Fujimoto, D.
|
|
|
27 |
S9 |
p. ix79
|
artikel
|
| 293 |
37P Expression pattern of cyclooxygenase-2 in carcinoma of cervix
|
Hameed, S.
|
|
|
27 |
S9 |
p. ix11
|
artikel
|
| 294 |
166P Extent of neck dissection in locally advanced thyroid cancers
|
Vaish, R.
|
|
|
27 |
S9 |
p. ix52
|
artikel
|
| 295 |
542P Factors related to the delay of medical treatment of Indonesian cancer patients
|
Gunawan, C.
|
|
|
27 |
S9 |
p. ix175-ix176
|
artikel
|
| 296 |
518P Feasibility and outocome of adult patients with osteosarcoma of the jaws. A single institute experience-
|
Oshiro, Y.
|
|
|
27 |
S9 |
p. ix168
|
artikel
|
| 297 |
258P First-line chemotherapies with FOLFIRINOX or gemcitabine plus nab-paclitaxel for unresectable pancreatic ductal adenocarcinoma in Japanese daily clinical practice
|
Yano, M.
|
|
|
27 |
S9 |
p. ix80
|
artikel
|
| 298 |
169P First-line FOLFOX-4 6 cetuximab in patients with RAS wild- type metastatic colorectal cancer: The open-label, randomized, phase 3 TAILOR trial
|
Qin, S.
|
|
|
27 |
S9 |
p. ix55
|
artikel
|
| 299 |
431P First-line treatment of advanced nonsquamous non-small cell lung cancer (NSCLC) in China in the era of precision medicine
|
Zhang, X.
|
|
|
27 |
S9 |
p. ix136-ix137
|
artikel
|
| 300 |
547P Focused analysis of major known fusion mutations in East Asian non-small cell lung cancers
|
Hsu, H.-L.
|
|
|
27 |
S9 |
p. ix177-ix178
|
artikel
|
| 301 |
260P Functional assessment of elderly cancer patients
|
Nagashima, F.
|
|
|
27 |
S9 |
p. ix81
|
artikel
|
| 302 |
249P Galectin-3 promotes cell proliferation and attenuates cytotoxic effect of paclitaxel via ERK signaling pathway in gastric cancer cells
|
Serizawa, N.
|
|
|
27 |
S9 |
p. ix78
|
artikel
|
| 303 |
466P Gefitinib retreatment beyond progression in advanced NSCLC patients with sensitive EGFR mutations
|
Sun, L.
|
|
|
27 |
S9 |
p. ix149
|
artikel
|
| 304 |
552P Genome characteristics of stage I lung adenocarcinoma associated with distinct progression patterns
|
Ke, D.
|
|
|
27 |
S9 |
p. ix179
|
artikel
|
| 305 |
22P Global epigenetic remodeling regulates chemoradiotherapy sensitivity of cancer
|
Li, D.
|
|
|
27 |
S9 |
p. ix6
|
artikel
|
| 306 |
32P Heterogeneity analysis of DW MRI as a biomarker for prediction of overall survival and 6 month PFS in GBM patients
|
Beigi, D.
|
|
|
27 |
S9 |
p. ix10
|
artikel
|
| 307 |
433P High Beclin-1 expression predicts prolonged survival in locally advanced non-small cell lung cancer receiving docetaxel-platinum induction chemotherapy
|
Lee, H.Y.
|
|
|
27 |
S9 |
p. ix137
|
artikel
|
| 308 |
295P High dose rate (HDR) brachytherapy for prostate cancer in the early stages
|
Bobkov, M.
|
|
|
27 |
S9 |
p. ix93
|
artikel
|
| 309 |
535P High flow nasal cannula oxygen for respiratory failure in patients with airway obstruction due to primary lung cancer
|
Kamei, T.
|
|
|
27 |
S9 |
p. ix174
|
artikel
|
| 310 |
389P Hormonal receptor in nasopharyngeal cancer based on sex and histopathology in Abdul Wahab Sjahranie General Hospital
|
Kelvin, S.
|
|
|
27 |
S9 |
p. ix120-ix121
|
artikel
|
| 311 |
553P How can we bring the analysis of circulating tumor cells (CTCs) in the point-of-care testing (POCT)? A Tokyo experience
|
Nagaya, N.
|
|
|
27 |
S9 |
p. ix180
|
artikel
|
| 312 |
11P Hypomagnesaemia in the context of cetuximab/panitumumab and proton pump inhibitor therapy
|
Joshi, R.
|
|
|
27 |
S9 |
p. ix3-ix4
|
artikel
|
| 313 |
532P Hypomagnesemia induced by cetuximab and panitumumab
|
Onikubo, T.
|
|
|
27 |
S9 |
p. ix173
|
artikel
|
| 314 |
46P Identification of novel biomarkers distinguishing pancreatic head cancer from distal cholangiocarcinoma discovered by proteomics analysis
|
Takenami, T.
|
|
|
27 |
S9 |
p. ix13
|
artikel
|
| 315 |
205P Identification of novel bypasses of KRAS addiction
|
Ly, S.H.
|
|
|
27 |
S9 |
p. ix63-ix64
|
artikel
|
| 316 |
21P Identification of the novel molecules mediating gastric cancer invasion based on genomic analysis of cancer-associated fibroblasts
|
Ishimoto, T.
|
|
|
27 |
S9 |
p. ix6
|
artikel
|
| 317 |
4P IGF-IR, but not EGFR, regulates DNA damage response in HeLa cells following irradiation
|
Nishagowri, M.
|
|
|
27 |
S9 |
p. ix2
|
artikel
|
| 318 |
558P IL-1beta mediates anti-progression activities in renal cell carcinoma by inducing MCP-1
|
Yang, J.-R.
|
|
|
27 |
S9 |
p. ix181
|
artikel
|
| 319 |
380P Immediate results HPV-induced cancer of the mouth and oropharynx in Kazakhstan
|
Adilbayev, G.
|
|
|
27 |
S9 |
p. ix118
|
artikel
|
| 320 |
109P Impact of FDG PET-CT in response evaluation of different molecular subtypes of locally advanced breast cancers post dose dense neoadjuvant chemotherapy
|
Reddy, L.G.
|
|
|
27 |
S9 |
p. ix32
|
artikel
|
| 321 |
369P Impact of glutamine supplements in altering the toxicity profile in head and neck cancer patients receiving concurrent chemoradiotherapy
|
Perumal, K.
|
|
|
27 |
S9 |
p. ix115
|
artikel
|
| 322 |
39P Impact of GSTP1 and ABCC4 genes polymorphism on outbreak of cyclophosphamide-based chemotherapy-induced grade 3/4 febrile neutropenia in Iranian breast cancer patients
|
Mobaraki, M.
|
|
|
27 |
S9 |
p. ix11-ix12
|
artikel
|
| 323 |
207P Impact of K-RAS mutation status on disease behavior and treatment outcome in metastatic colorectal cancer patients
|
Rasmy, A.
|
|
|
27 |
S9 |
p. ix64
|
artikel
|
| 324 |
376P Impact of pre-radiotherapy haemoglobin levels on treatment breaks in locally advanced head and neck squamous cell carcinoma getting concurrent chemoradiation
|
Narayanasamy, R.K.
|
|
|
27 |
S9 |
p. ix117
|
artikel
|
| 325 |
112P Impact of surgery on psychological distress in women with breast cancer
|
Jadoon, N.A.
|
|
|
27 |
S9 |
p. ix33
|
artikel
|
| 326 |
247P Impact of the preoperative neutrophil-to-lymphocyte ratio in the short term outcomes of patients with gastric cancer
|
Miyamoto, R.
|
|
|
27 |
S9 |
p. ix77
|
artikel
|
| 327 |
41P Impact on prognosis of cellular CD 69 expression with CD 38 in Egyptian chronic lymphocytic leukemia
|
Elbaiomy, M.A.
|
|
|
27 |
S9 |
p. ix12
|
artikel
|
| 328 |
570P Implementation and evaluation of medicine & therapeutic information service by clinical pharmacists at a private cancer center
|
Patel, D.
|
|
|
27 |
S9 |
p. ix185-ix186
|
artikel
|
| 329 |
183P Importance of carcinoembryonic antigen on disease control and survival in elderly rectal cancer patients with comorbid condition
|
Koo, T.
|
|
|
27 |
S9 |
p. ix57
|
artikel
|
| 330 |
234P Improved nutritional status and prognosis in patients with malignant gastroduodenal obstruction using Niti-S duodenal stent
|
Shimada, M.
|
|
|
27 |
S9 |
p. ix74
|
artikel
|
| 331 |
528P Incidence, risk factors, treatment outcomes and prognosis of acute kidney injury caused by chemotherapy in patients with lung cancer
|
Hwang, I.G.
|
|
|
27 |
S9 |
p. ix171-ix172
|
artikel
|
| 332 |
391P Incremental value of preoperative CT in the surgical management of papillary thyroid cancer
|
Mahajan, A.
|
|
|
27 |
S9 |
p. ix121
|
artikel
|
| 333 |
12P Individualized breast cancer therapy using Mcl-1 inhibition based combination
|
Bashari, M.H.
|
|
|
27 |
S9 |
p. ix4
|
artikel
|
| 334 |
377P Induction chemotherapy with APF (bevacizumab + cisplatin + 5-fluorouracil) for betel-nut-chewing associated head and neck squamous cell carcinoma - a retrospective analysis
|
Huang, H.-C.
|
|
|
27 |
S9 |
p. ix117
|
artikel
|
| 335 |
94P Influence of different treatment planning techniques on radiation doses to the heart, left anterior descending coronary artery and lungs in the radiotherapy of left-sided breast cancer patients
|
Hadjilooei, F.
|
|
|
27 |
S9 |
p. ix27-ix28
|
artikel
|
| 336 |
368P Influence of pre-RT haemoglobin levels on mucositis in locally advanced head and neck squamous cell carcinoma treated with concurrent chemo radiation
|
Perumal, K.
|
|
|
27 |
S9 |
p. ix115
|
artikel
|
| 337 |
129P Inhibition of breast cancer cell explosion rate by irinotecan loaded zinc oxide nanoparticles through E2F3/Akt signaling circuits: A milestone in cancer gene therapy
|
Vimala, K.
|
|
|
27 |
S9 |
p. ix38-ix39
|
artikel
|
| 338 |
292P Inhibition of endothelial cell-specific molecule-1 promotes the tumorigenicity and metastasis of prostate cancer cells
|
Hsieh, Y.-H.
|
|
|
27 |
S9 |
p. ix92
|
artikel
|
| 339 |
16P Inhibition of invasion and migration by n-3 fatty acids in PC3 cells
|
Ohta, S.
|
|
|
27 |
S9 |
p. ix5
|
artikel
|
| 340 |
48P Inhibition of LAP2a can suppress cell aggressiveness in breast cancer
|
Li, X.
|
|
|
27 |
S9 |
p. ix14
|
artikel
|
| 341 |
181P Initial CEA and CA19-9 level were associated with pathologic outcome of locally advanced rectal cancer after neoadjuvant chemotherapy with or without radiotherapy: Results from a prospective study
|
Zhang, J.
|
|
|
27 |
S9 |
p. ix57
|
artikel
|
| 342 |
290P Initial outcome of definitive intensity modulated RT in treatment of bone oligometastatic prostate cancer
|
Qi, X.
|
|
|
27 |
S9 |
p. ix91
|
artikel
|
| 343 |
43P Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer
|
Li, G.
|
|
|
27 |
S9 |
p. ix13
|
artikel
|
| 344 |
233P Intensiveneoadjuvantchemotherapyfollowedby chemoradiation and intraluminal HDR brachytherapyin esophageal cancer
|
Samiei, F.
|
|
|
27 |
S9 |
p. ix73
|
artikel
|
| 345 |
57P Inter-observer variability in programmed death-ligand 1 (PD-L1) immunohistochemistry scoring in non small cell lung cancer (NSCLC)
|
Thai, A.
|
|
|
27 |
S9 |
p. ix16-ix17
|
artikel
|
| 346 |
76P Invasive lobular breast cancer, a 14 years experience at single cancer hospital from Pakistan.
|
Ali, S.
|
|
|
27 |
S9 |
p. ix22-ix23
|
artikel
|
| 347 |
408P Ipilimumab after nivolumab therapy for melanoma patients in Asia
|
Tsutsumida, A.
|
|
|
27 |
S9 |
p. ix127
|
artikel
|
| 348 |
410P Ipilimumab efficacy and safety profile in metastatic melanoma in Saskatchewan
|
Papneja, N.
|
|
|
27 |
S9 |
p. ix127-ix128
|
artikel
|
| 349 |
267P Irinotecan monotherapy as third line treatment for advanced gastric cancer patients refractory fluoropyrimidine, platinum and taxanes harboring UGT1A1*1/*1. *1/*6 or *1/*28
|
Sugimoto, N.
|
|
|
27 |
S9 |
p. ix83
|
artikel
|
| 350 |
195P Irinotecan plus cetuximab (Cmab) versus irinotecan plus panitumumab (Pmab) in patients (pts) with wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) as third- line in daily practice
|
Sugimoto, N.
|
|
|
27 |
S9 |
p. ix61
|
artikel
|
| 351 |
71P Is St Gallen 2013 intrinsic subtype classification valid in routine practice?
|
Bandidwattanawong, C.
|
|
|
27 |
S9 |
p. ix21
|
artikel
|
| 352 |
563P Is triple negative breast cancer really bad? 10 year audit from a tertiary center
|
Chelakkot G, P.
|
|
|
27 |
S9 |
p. ix182-ix183
|
artikel
|
| 353 |
92P Knowledge, attitude and prevention practice about breast cancer among female nursing students in University of Nursing (Yangon), Myanmar
|
Aye, T.T.
|
|
|
27 |
S9 |
p. ix27
|
artikel
|
| 354 |
124P Lack of HDAC1 and HDAC2 promote breast cancer aggressiveness
|
Kamarulzaman, N.S.
|
|
|
27 |
S9 |
p. ix37
|
artikel
|
| 355 |
519P Lanthanum nanoparticles synthesized from fenugreek seed extract as targeted therapy for osteosarcoma
|
Dam, D.
|
|
|
27 |
S9 |
p. ix168
|
artikel
|
| 356 |
571P Level of cancer awareness among college students from South India
|
Mushini, V.
|
|
|
27 |
S9 |
p. ix186
|
artikel
|
| 357 |
232P Locally advanced esophageal cancer - evaluation of addition ofchemotherapypriortochemoradiation
|
Saha, S.
|
|
|
27 |
S9 |
p. ix73
|
artikel
|
| 358 |
130P Locoregional treatment in de novo stage IV breast cancer: A retrospective study of Chinese population
|
Wang, W.
|
|
|
27 |
S9 |
p. ix39
|
artikel
|
| 359 |
47P Loss-of-function PTPRT and PTPRD mutations predict bevacizumab resistance in metastatic colorectal cancer patients
|
Tan, K.T.
|
|
|
27 |
S9 |
p. ix14
|
artikel
|
| 360 |
355P Lower radiotherapy dose in patients with Hodgkin's lymphoma- is it comparable to the past standard?
|
Yadav, B.S.
|
|
|
27 |
S9 |
p. ix110-ix111
|
artikel
|
| 361 |
458P Lung cancer diagnostic delay secondary to misdiagnosis with lung tuberculosis in Dr. Moewardi Public Hospital pulmonary ward Surakarta
|
Rima, A.
|
|
|
27 |
S9 |
p. ix147
|
artikel
|
| 362 |
115P Male breast cancer - A single institution review
|
Hariharan, N.
|
|
|
27 |
S9 |
p. ix34
|
artikel
|
| 363 |
38P Mena INV: A prospective bio-marker of glioma under hypoxia
|
Bhagat, M.
|
|
|
27 |
S9 |
p. ix11
|
artikel
|
| 364 |
77P Menarche age, contraception use and gravidity as risk factors for breast cancer: Associations in a case-control study
|
Moslemi, D.
|
|
|
27 |
S9 |
p. ix23
|
artikel
|
| 365 |
272P Meta-analysis of intracorporeal or extracorporeal anastomosis after laparoscopic total gastrectomy for gastric cancer: Which is better?
|
Nguyen, A.T.T.
|
|
|
27 |
S9 |
p. ix84
|
artikel
|
| 366 |
476P Meta-analysis of randomised clinical trials comparing erlotinib alone with erlotinib plus chemotherapy in patients
|
Chen, C.
|
|
|
27 |
S9 |
p. ix153
|
artikel
|
| 367 |
579P Methodological considerations for clinical equivalence of bevacizumab biosimilars
|
Heinzmann, B.
|
|
|
27 |
S9 |
p. ix188
|
artikel
|
| 368 |
287P Metronomic cyclophosphamide in metastatic castrate resistantprostatecancer:Experiencefromatertiarycancer care center
|
Dabkara, D.
|
|
|
27 |
S9 |
p. ix90-ix91
|
artikel
|
| 369 |
147P Midline crossing grade I to grade III gliomas: Impact of high dose XRT on survival
|
Mushtaq, K.
|
|
|
27 |
S9 |
p. ix44-ix45
|
artikel
|
| 370 |
45P MiR-183 is frequenty methylated and related to poor survival in human hepatocellular carcinoma
|
Anwar, S.L.
|
|
|
27 |
S9 |
p. ix13
|
artikel
|
| 371 |
415P Modification CT/MRI demonstration after radiation therapy for pituitary somatotropinomas
|
Issaeva, S.S.
|
|
|
27 |
S9 |
p. ix130
|
artikel
|
| 372 |
203P Molecular analysis of predictive biomarkers-KRAS, BRAF, NRAS and PIK3CA in colon cancer and correlation of clinico- pathological features with mutation profiling and therapeutic response in Indian patient cohort
|
Patil, H.A.
|
|
|
27 |
S9 |
p. ix63
|
artikel
|
| 373 |
257P Molecular mechanisms involved in the synergistic interaction of novel formulated curcumin with gemcitabine in pancreatic cancer cells
|
Avan, A.
|
|
|
27 |
S9 |
p. ix80
|
artikel
|
| 374 |
31P Molecular mechanisms of regulation of proliferation markers of breast cancer in young patients
|
Zakirova, K.T.
|
|
|
27 |
S9 |
p. ix9-ix10
|
artikel
|
| 375 |
79P Molecular targeted therapy for Her2 positive breast cancer in private sector: Yangon experience
|
Khine, M.
|
|
|
27 |
S9 |
p. ix23
|
artikel
|
| 376 |
262P MRI and MDCT for the diagnosis of pancreatoduodenal zone tumors
|
Teshaev, O.R.
|
|
|
27 |
S9 |
p. ix81
|
artikel
|
| 377 |
241P NAB-paclitaxelasthird-linetherapyafterfailureof gemcitabineand5-fluorouracil(5-FU)basedcombinationsin advancedgallbladdercancerpatients
|
Goel, V.
|
|
|
27 |
S9 |
p. ix75-ix76
|
artikel
|
| 378 |
101P Neoadjuvant chemotherapy for locally advanced breast cancer
|
Fomenko, Y.
|
|
|
27 |
S9 |
p. ix30
|
artikel
|
| 379 |
277P Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis
|
Malik, B.
|
|
|
27 |
S9 |
p. ix86
|
artikel
|
| 380 |
226P Neoadjuvant chemotherapy in locally advanced gall bladder cancer: A retrospective tertiary care centre experience
|
Sahu, A.
|
|
|
27 |
S9 |
p. ix71
|
artikel
|
| 381 |
177P New staging system for colorectal cancer patients with synchronous peritoneal metastasis in accordance with the Japanese Classification of Colorectal Carcinoma: A multi-institutional study.
|
Noura, S.
|
|
|
27 |
S9 |
p. ix56
|
artikel
|
| 382 |
577P Nicotine dependence assessment using Fagerstrom test and Nicotine Replacement therapy (NRT) recommendation techniques for smoking cessation among Paniya tribes
|
Rozario, H.P.
|
|
|
27 |
S9 |
p. ix187-ix188
|
artikel
|
| 383 |
327P Nomogram prediction for overall survival of patients diagnosed with cervical cancer
|
Jagadeesan, S.
|
|
|
27 |
S9 |
p. ix102
|
artikel
|
| 384 |
231P Nomogram to predict prognosis in thoracic esophageal squamous cell carcinoma after neoadjuvant radiotherapy or chemoradiotherapy
|
Deng, W.
|
|
|
27 |
S9 |
p. ix73
|
artikel
|
| 385 |
244P NOP14 promotes invasion and metastasis by maintaining mutant p53-induced oncogenic signaling in pancreatic cancer
|
Du, Y.
|
|
|
27 |
S9 |
p. ix76-ix77
|
artikel
|
| 386 |
2P Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST
|
Shiao, H.-Y.
|
|
|
27 |
S9 |
p. ix1
|
artikel
|
| 387 |
162P Novel isoxazolyl chromones antagonizing ERa induces anticancer activity via triggering caspase-3 activation
|
Kaushik, S.
|
|
|
27 |
S9 |
p. ix50
|
artikel
|
| 388 |
381P Novel treatments for betel-nut related HNSCC in Taiwan
|
Chen, J.-P.
|
|
|
27 |
S9 |
p. ix118
|
artikel
|
| 389 |
190P Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by the Glasgow Prognostic Score (GPS)
|
Sasaki, T.
|
|
|
27 |
S9 |
p. ix59-ix60
|
artikel
|
| 390 |
419P Optimal follow-up strategy for resected neuroendocrine tumours: A systematic review
|
Patel, D.
|
|
|
27 |
S9 |
p. ix131
|
artikel
|
| 391 |
187P Optimal treatment strategy of first-line oxaliplatin (Oxa)- containing therapy in metastatic colorectal cancer (mCRC): A trial-level meta-analysis
|
Moriwaki, T.
|
|
|
27 |
S9 |
p. ix58-ix59
|
artikel
|
| 392 |
310P Oral leukoplakia in women treated with long-term pegylated liposomal doxorubicin
|
Nomura, H.
|
|
|
27 |
S9 |
p. ix97
|
artikel
|
| 393 |
468P Osimertinib in patients with T790M mutation positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data
|
Ahn, M.-J.
|
|
|
27 |
S9 |
p. ix150
|
artikel
|
| 394 |
353P Outcome and prognostic factors in diffuse large B-cell lymphoma
|
Mahajan, R.
|
|
|
27 |
S9 |
p. ix110
|
artikel
|
| 395 |
75P Outcomes in postmenopausal women with hormone receptor positive, HER-2 negative T2N0 breast cancer without adjuvant chemotherapy
|
Kim, Y.S.
|
|
|
27 |
S9 |
p. ix22
|
artikel
|
| 396 |
343P Outcomes of good risk AML from a tertiary cancer centre: Is good always good?
|
Ghosh, J.
|
|
|
27 |
S9 |
p. ix107
|
artikel
|
| 397 |
378P Outcomes of p 16 positive oropharyngeal squamous cell carcinoma treated with radiotherapy - Results from a tertiary care center in South India
|
Sashidharan, S.
|
|
|
27 |
S9 |
p. ix117
|
artikel
|
| 398 |
145P Outcomes of treatment of glioblastoma multiforme: A single institution experience from South India
|
George, A.S.
|
|
|
27 |
S9 |
p. ix44
|
artikel
|
| 399 |
294P Over diagnosis of prostate cancer in Eurasian men by PSA and PHI: example of heterosis
|
Xie, Y.
|
|
|
27 |
S9 |
p. ix92
|
artikel
|
| 400 |
86P Overview of breast cancer management: Yangon private sector cancer care
|
Mon, S.
|
|
|
27 |
S9 |
p. ix25
|
artikel
|
| 401 |
494P Palliative care in Iran, two year experience of the Firoozgar Palliative Medicine Unit
|
Malayeri, R.
|
|
|
27 |
S9 |
p. ix160
|
artikel
|
| 402 |
556P Pathological characteristics according to age at diagnosis in 2929 men with prostate cancer
|
Song, D.
|
|
|
27 |
S9 |
p. ix181
|
artikel
|
| 403 |
104P Pathologic tumor response & long term outcome with neoadjuvant trastuzumab in Her-2 positive breast cancer
|
Zeeshan, S.
|
|
|
27 |
S9 |
p. ix31
|
artikel
|
| 404 |
569P Patterns of cancer in the University of Gondar Hospital, NorthWest Ethiopia
|
Deressa, B.T.
|
|
|
27 |
S9 |
p. ix185
|
artikel
|
| 405 |
291P PD-L1 over expression may predict disease aggressiveness in prostate cancer
|
Hashimoto, Y.
|
|
|
27 |
S9 |
p. ix91-ix92
|
artikel
|
| 406 |
27P Pectin-Chitosan conjugates novel biomaterial as platform for colon cancer drug delivery
|
Singh, A.V.
|
|
|
27 |
S9 |
p. ix7-ix8
|
artikel
|
| 407 |
407P Pembrolizumab Expanded Access Program (EAP) in Taiwan for patients with progressive advanced melanoma after prior ipilimumab treatment
|
Yang, C.-K.
|
|
|
27 |
S9 |
p. ix127
|
artikel
|
| 408 |
385P Pembrolizumab for cisplatin-failure recurrent/metastatic head and neck squamous cell carcinoma
|
Chen, W.-C.
|
|
|
27 |
S9 |
p. ix119
|
artikel
|
| 409 |
562P Peritumoral lymphoid infiltrate in renal cell carcinoma
|
Oleshko, O.
|
|
|
27 |
S9 |
p. ix182
|
artikel
|
| 410 |
367P Persistent elevation of plasma interleukin-8 or interferon-
γ
after curative chemoradiotherapy predict early tumor recurrence and poor survival outcomes in patients with head and neck squamous cell carcinoma
|
Lin, Y.-L.
|
|
|
27 |
S9 |
p. ix114-ix115
|
artikel
|
| 411 |
473P Personalized treatment of advanced non-small cell lung cancer based on excision repair cross-complementation group 1 (ERCC-1) expression
|
Naghi, K.A.
|
|
|
27 |
S9 |
p. ix151-ix152
|
artikel
|
| 412 |
44P Pharmacogenetic methods of personalization in medical treatment of colon cancer
|
Ibragimov, J.
|
|
|
27 |
S9 |
p. ix13
|
artikel
|
| 413 |
235P Phase 1b study of nimotuzumab in combination with concurrent chemoradiotherapy in Japanese patients with locally advanced esophageal cancer
|
Ura, T.
|
|
|
27 |
S9 |
p. ix74
|
artikel
|
| 414 |
100P Phase III of study of docetaxel and carboplatin with or without doxorubicin hydrochloride and cyclophosphamide in treating women with triple negative breast cancer
|
Najafi, S.
|
|
|
27 |
S9 |
p. ix30
|
artikel
|
| 415 |
460P Phase I/II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL; TORG1424/OLCSG1402): results of the phase I part
|
Bessho, A.
|
|
|
27 |
S9 |
p. ix148
|
artikel
|
| 416 |
189P Phase II trial of S-1 plus panitumumab for wild-type KRAS unresectable colorectal cancer patients previously treated with 5-fluorouracil (5-FU), oxaliplatin and irinotecan (KSCC1103)
|
Sakamoto, Y.
|
|
|
27 |
S9 |
p. ix59
|
artikel
|
| 417 |
406P Phase 2 study of nivolumab (NIVO) in Japanese patients with previously untreated advanced melanoma: long-term efficacy and safety
|
Yamazaki, N.
|
|
|
27 |
S9 |
p. ix126-ix127
|
artikel
|
| 418 |
78P Population based mammographic screening in India: Analysis from community outreach cancer screening program
|
Bisht, S.S.
|
|
|
27 |
S9 |
p. ix23
|
artikel
|
| 419 |
455P Population-level impact of EGFR mutation testing in nonsquamous NSCLC
|
McKeage, M.J.
|
|
|
27 |
S9 |
p. ix146
|
artikel
|
| 420 |
201P POU5F1 gene expression in colorectal cancer: a novel prognostic marker after curative surgical resection
|
Miyoshi, N.
|
|
|
27 |
S9 |
p. ix62-ix63
|
artikel
|
| 421 |
358P PPAR GAMMA Agonist in combination with BCR/ABL TKI in patients of CML-CP with suboptimal molecular response
|
Malhotra, H.
|
|
|
27 |
S9 |
p. ix111
|
artikel
|
| 422 |
456P Practical use of osimertinib in Japanese patients with EGFR T790M mutation positive advanced non-small-cell lung cancer
|
Kotake, M.
|
|
|
27 |
S9 |
p. ix147
|
artikel
|
| 423 |
493P_PR A prospective study on quality of life among persons with lung cancer, before and after chemotherapy treatment - evidence from South India
|
Katpattil, S.
|
|
|
27 |
S9 |
p. ix159
|
artikel
|
| 424 |
491P_PR Background pain vs breakthrough pain? Which is the priority of cancer pain treatment
|
Baek, S.K.
|
|
|
27 |
S9 |
p. ix159
|
artikel
|
| 425 |
568P_PR Changes in household income levels as a result of cancer diagnosis and treatment – A single centre study
|
Agarwal, A.
|
|
|
27 |
S9 |
p. ix185
|
artikel
|
| 426 |
567P_PR Diagnostic delay in oncology: Is there a need for increasing cancer awareness among primary care physicians of developing countries?
|
Miriyala, R.
|
|
|
27 |
S9 |
p. ix185
|
artikel
|
| 427 |
428P_PR Domestic cooking fuel as a risk factor for lung cancer in women - A case control study
|
Sha, A.
|
|
|
27 |
S9 |
p. ix134-ix135
|
artikel
|
| 428 |
26P Pre and post chemotherapy circulating oxidative stress parameters in breast cancer patients
|
Moslemi, D.
|
|
|
27 |
S9 |
p. ix7
|
artikel
|
| 429 |
167P Predictive factors for central neck lymph node metastasis in patients with papillary thyroid microcarcinoma without suspicious metastasis by preoperative ultrasonography
|
Oh, H.
|
|
|
27 |
S9 |
p. ix52
|
artikel
|
| 430 |
255P Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-transferase P1 for FOLFIRINOX in unresectable pancreatic cancer
|
Tezuka, S.
|
|
|
27 |
S9 |
p. ix79-ix80
|
artikel
|
| 431 |
110P Predictive value of tumor response rate for axillary response of neoadjuvant chemotherapy in patients with clinically nodepositive breast cancer
|
Kim, H.S.
|
|
|
27 |
S9 |
p. ix32-ix33
|
artikel
|
| 432 |
325P Preliminary review of computed tomography (CT)-based image-guided brachytherapy (IGBT) in treatment of cervical cancers: The National Cancer Institute (NCI) experience
|
Salimin, N.
|
|
|
27 |
S9 |
p. ix101
|
artikel
|
| 433 |
375P Prevalence of head and neck cancers and tobacco use among Malayali tribes, Yelagiri Hills, Tamil nadu, India
|
Francis, D.L.
|
|
|
27 |
S9 |
p. ix116-ix117
|
artikel
|
| 434 |
96P Prevalence of hypothyroidism among breast cancer patients treated with radiation to the supraclavicular field: A single center survey
|
Kikawa, Y.
|
|
|
27 |
S9 |
p. ix28
|
artikel
|
| 435 |
585P_PR Evaluation of fingerprint loss in patients under paclitaxel based chempotherapy regimen
|
Sarbaz, S.
|
|
|
27 |
S9 |
p. ix189
|
artikel
|
| 436 |
530P_PR Evaluation of quality of supportive care in cancer patients receiving chemotherapy: An experience from a developing country
|
Patel, H.
|
|
|
27 |
S9 |
p. ix172
|
artikel
|
| 437 |
148P Primary CNS lymphoma - Our experience with this rare disease
|
Pathak, A.
|
|
|
27 |
S9 |
p. ix45
|
artikel
|
| 438 |
239P Primary squamous cell carcinoma of the stomach (PSCCS) - A systematic review and meta-analysis
|
Thottian, A.G.
|
|
|
27 |
S9 |
p. ix75
|
artikel
|
| 439 |
517P Primitive neuroectodermal tumor of kidney: analysis of 20 cases
|
Tiwari, P.
|
|
|
27 |
S9 |
p. ix167-ix168
|
artikel
|
| 440 |
237P Prognostic characteristics of esophageal cancer patients with multiple primary cancers: A retrospective single institution study
|
Baba, Y.
|
|
|
27 |
S9 |
p. ix74-ix75
|
artikel
|
| 441 |
549P Prognostic factors and clinical outcomes of malignant pleural mesothelioma in a real world-setting: An Asian cohort
|
Wu, T.-H.
|
|
|
27 |
S9 |
p. ix178
|
artikel
|
| 442 |
508P Prognostic factors of soft tissue sarcoma (STS) treated with pazopanib from Nishinomiya Sarcoma Cohort Study (NSCS)
|
Narahara, H.
|
|
|
27 |
S9 |
p. ix165
|
artikel
|
| 443 |
185P Prognostic impact of tumor location and use of monoclonal antibodies in patients with metastatic colorectal cancer
|
Nakamura, M.
|
|
|
27 |
S9 |
p. ix58
|
artikel
|
| 444 |
121P Prognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India
|
Das, C.K.
|
|
|
27 |
S9 |
p. ix36
|
artikel
|
| 445 |
90P Prognostic value of vitamin-D level in non-metastatic breast cancer patients in Saudi Arabia
|
Elsamany, S.
|
|
|
27 |
S9 |
p. ix26
|
artikel
|
| 446 |
470P Progression-free survival and response rate with EGFR tyrosine kinase inhibitor treatment according to EGFR mutation subtype in advanced lung adenocarcinoma
|
Chai, C.S.
|
|
|
27 |
S9 |
p. ix150-ix151
|
artikel
|
| 447 |
213P Prominin-1-targeted apoferritin nanoparticle carrying irinotecan as a novel radiosensitizer for colorectal cancer stem-like cells
|
Chen, J.L.-Y.
|
|
|
27 |
S9 |
p. ix66
|
artikel
|
| 448 |
42P Promoter hypermethylation of BRCA1, DAPK1 and RASSF1A is associated with increase mortality among breast cancer patients
|
Yadav, P.
|
|
|
27 |
S9 |
p. ix12
|
artikel
|
| 449 |
540P_PR What are the patient expectations from palliative chemotherapy?
|
Takeuchi, N.
|
|
|
27 |
S9 |
p. ix175
|
artikel
|
| 450 |
132P Quality of life and psychosocial needs of metastatic breast cancer patients
|
Mehmood, T.
|
|
|
27 |
S9 |
p. ix39
|
artikel
|
| 451 |
279P Quality of life during gemcitabine plus cisplatin or gemcitabine plus carboplatin for urothelial carcinoma
|
Hatakeyama, S.
|
|
|
27 |
S9 |
p. ix87
|
artikel
|
| 452 |
427P Quantitative severity of pulmonary emphysema as a prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer
|
Lee, S.J.
|
|
|
27 |
S9 |
p. ix134
|
artikel
|
| 453 |
89P Questionnaire survey on patients' preference for orally disintegrating tablets or granules of S-1 in postoperative adjuvant treatment for breast cancer
|
Fukada, I.
|
|
|
27 |
S9 |
p. ix26
|
artikel
|
| 454 |
6P Quinazoline clubbed s-triazine derivatives as VEGFR2 kinase inhibitor: Design, synthesis, docking, antiproliferative and antiangiogenic activity on cancer-induced chick embryo
|
Verma, A.
|
|
|
27 |
S9 |
p. ix2
|
artikel
|
| 455 |
324P Radiation response assessment by hybrid positron emission tomography/magnetic resonance imaging for cervical cancer treatment
|
Choo, B.A.
|
|
|
27 |
S9 |
p. ix101
|
artikel
|
| 456 |
95P Radiotherapy (RT) for breast cancer patients- clinical implementation of the first ever Tomotherapy-H in a tertiary cancer centre in India
|
Hanumanthappa, N.
|
|
|
27 |
S9 |
p. ix28
|
artikel
|
| 457 |
153P Ramucirumab safety in East Asian (EA) compared to non-EA patients: A meta-analysis of adverse events (AEs) in 6 global, randomized, double-blind, phase 3 clinical trials
|
Chung, H.C.
|
|
|
27 |
S9 |
p. ix47-ix48
|
artikel
|
| 458 |
546P Randomised controlled trial comparing nicotine replacement therapy (NRT) plus brief counselling and brief counselling alone on smoking cessation in patients prone to lung cancer using a breath carbon monoxide (CO) monitor
|
Johns, D.A.
|
|
|
27 |
S9 |
p. ix177
|
artikel
|
| 459 |
155P Randomized controlled trial of CT-guided versus laparoscopic radiofrequency ablation in recurrent small hepatocellular carcinoma against the diaphragmatic dome
|
Zheng, Q.
|
|
|
27 |
S9 |
p. ix48-ix49
|
artikel
|
| 460 |
322P Rapid genetic screening experience among endometrial cancer about Lynch syndrome by surgeon
|
Kim, M.K.
|
|
|
27 |
S9 |
p. ix100
|
artikel
|
| 461 |
202P Reactive oxygen species modulator 1 (Romo1) as a prognostic biomarker for colorectal cancer patients who have curative resection
|
Kim, H.J.
|
|
|
27 |
S9 |
p. ix63
|
artikel
|
| 462 |
487P Real-world feasibility of adjuvant TAC with pegylated G-CSF in resectable breast cancer: A single-center experience
|
Park, J.H.
|
|
|
27 |
S9 |
p. ix158
|
artikel
|
| 463 |
348P Real world practice patterns in multiple myeloma patients presenting with pleural effusion
|
Kim, K.H.
|
|
|
27 |
S9 |
p. ix108-ix109
|
artikel
|
| 464 |
463P Real-world treatment patterns for advanced EGFR wild-type NSCLC in second or third line in a large US database
|
Li, Y.
|
|
|
27 |
S9 |
p. ix148-ix149
|
artikel
|
| 465 |
256P Recombination signal binding protein for immunoglobulin- kappa-J region (RBPJ) and Mastermind-like 3 (MAML3) are potential therapeutic targets for pancreatic cancer
|
Yamasaki, A.
|
|
|
27 |
S9 |
p. ix80
|
artikel
|
| 466 |
383P Recurrent head and neck squamous cell carcinoma
|
Wu, S.-Y.
|
|
|
27 |
S9 |
p. ix118-ix119
|
artikel
|
| 467 |
105P Retrospective analysis of complete pathological response in locally advanced HER2 positive breast cancer patients treated with neoadjuvant chemotherapy associated to trastuzumab at Brazilian National Cancer Institute
|
Nunes, A.S.
|
|
|
27 |
S9 |
p. ix31
|
artikel
|
| 468 |
574P Retrospective evaluation of the efficacy and safety of rivaroxaban in patients with cancer associated venous thromboembolism
|
Oh, S.B.
|
|
|
27 |
S9 |
p. ix187
|
artikel
|
| 469 |
511P Retrospective study of sarcoma in practical and developmental therapeutics in Japan
|
Nishikawa, T.
|
|
|
27 |
S9 |
p. ix166
|
artikel
|
| 470 |
388P Review of nasopharygeal carcinoma cases in radiation oncology unit, Yangon General Hospital
|
Than, N.W.
|
|
|
27 |
S9 |
p. ix120
|
artikel
|
| 471 |
25P Review of reproductive risk factors in breast cancer patients in Toungoo General Hospital, Myanmar
|
Nwe, K.K.K.
|
|
|
27 |
S9 |
p. ix7
|
artikel
|
| 472 |
82P Risk factors for breast cancer: A case-control study among post-menopausal women in Pakistan
|
Jadoon, N.A.
|
|
|
27 |
S9 |
p. ix24
|
artikel
|
| 473 |
534P Risk factors predicting failure of nutritional intervention in cancer patients
|
Feng, H.
|
|
|
27 |
S9 |
p. ix173
|
artikel
|
| 474 |
211P Risk of selected gastrointestinal and hepatic toxicities in cancer patients treated with nintedanib; a meta-analysis.
|
Eldin, N.Bahi
|
|
|
27 |
S9 |
p. ix65
|
artikel
|
| 475 |
176P Robotic anterior resection of rectal cancer without abdominal incision: transanal rectal eversion and resection for specimen extraction: A preliminary and feasibility study
|
Zhu, D.
|
|
|
27 |
S9 |
p. ix55
|
artikel
|
| 476 |
514P Role of dose-intense chemotherapy before limb-sparing surgery in Ewing sarcoma
|
Mishra, A.N.
|
|
|
27 |
S9 |
p. ix167
|
artikel
|
| 477 |
462P ROS1 fusion Chinese lung adenocarcinoma patients treated with crizotinib detected using next-generation genotyping from ctDNA
|
Niu, X.
|
|
|
27 |
S9 |
p. ix148
|
artikel
|
| 478 |
134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study)
|
Shien, T.
|
|
|
27 |
S9 |
p. ix39-ix40
|
artikel
|
| 479 |
510P Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice
|
Inagaki, C.
|
|
|
27 |
S9 |
p. ix165-ix166
|
artikel
|
| 480 |
191P Safety and preliminary efficacy of modified FOLFOXIRI in advanced colorectal cancer: Single institution experience
|
Cai, Y.
|
|
|
27 |
S9 |
p. ix60
|
artikel
|
| 481 |
486P Samarium-153 adjuvant to palliative local radiotherapy for bone metastases: Efficacy and complications
|
Davodian, S.
|
|
|
27 |
S9 |
p. ix157
|
artikel
|
| 482 |
268P Sarcopenia may be associated with the mortality in patients with hepatocellular carcinoma
|
Kim, S.E.
|
|
|
27 |
S9 |
p. ix83
|
artikel
|
| 483 |
98P Seaweed extract and fucoidan on breast cancer cell proliferation
|
Chavoshi, S.H.
|
|
|
27 |
S9 |
p. ix28-ix29
|
artikel
|
| 484 |
313P Secretory cells expansion as a very early event in ovarian high-grade serous carcinoma
|
Asaturova, A.
|
|
|
27 |
S9 |
p. ix98
|
artikel
|
| 485 |
230P Selective gastric cancer patients with peritoneal dissemination benefit from palliative gastrectomy after palliative chemotherapy: Results from two high-volume institutions
|
Nie, R.-C.
|
|
|
27 |
S9 |
p. ix72-ix73
|
artikel
|
| 486 |
7P Selenium-enriched polysacchride green tea extract alters the early stage hepatocellular carcinoma by angiogenesis hypoxia and metastatic inhibition
|
Kumar, V.
|
|
|
27 |
S9 |
p. ix2-ix3
|
artikel
|
| 487 |
413P Sensitization of melanoma cells to nitrosourea treatment by ROS-inducing IKKβ inhibitor
|
Tse, A.K.-W.
|
|
|
27 |
S9 |
p. ix128
|
artikel
|
| 488 |
106P Sentinel lymph node after neoadjuvant chemotherapy in patients with locally advanced breast cancer
|
Youssef, A. Chikh
|
|
|
27 |
S9 |
p. ix31-ix32
|
artikel
|
| 489 |
278P Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for advanced upper-tract urothelial cancer patient with impaired renal function
|
Yoneyama, T.
|
|
|
27 |
S9 |
p. ix86-ix87
|
artikel
|
| 490 |
420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors- retrospective multi-center study in Taiwan
|
Liu, C.-T.
|
|
|
27 |
S9 |
p. ix131
|
artikel
|
| 491 |
182P Serum CEA directed PET-CECT scan strategy for followup of colorectal cancer post curative therapy
|
Vallam, K.C.
|
|
|
27 |
S9 |
p. ix57
|
artikel
|
| 492 |
293P Serum free testosterone predicts a positive prostate biopsy in patients with PSA levels of 4-10ng/ml without any clinical findings
|
Ishizuya, Y.
|
|
|
27 |
S9 |
p. ix92
|
artikel
|
| 493 |
228P Significance of para-aortic lymph node dissection for advanced gastric cancer patients following DCS therapy
|
Fushida, S.
|
|
|
27 |
S9 |
p. ix72
|
artikel
|
| 494 |
208P Significance of the difference in size of liver tumors in management of patients with colorectal liver metastases
|
Ichida, K.
|
|
|
27 |
S9 |
p. ix64-ix65
|
artikel
|
| 495 |
350P Single center experience of diffuse large b-cell lymphoma patients with central nervous system relapse
|
Qureshi, F.
|
|
|
27 |
S9 |
p. ix109
|
artikel
|
| 496 |
56P Single circulating tumor cells RNA profiling by label-free enrichment and active single cell selection on an integrated fluidic system
|
Lee, Y.F.
|
|
|
27 |
S9 |
p. ix15-ix16
|
artikel
|
| 497 |
330P Skeletal muscle metastases from cervical cancer (two cases)
|
Pervin, S.
|
|
|
27 |
S9 |
p. ix102-ix103
|
artikel
|
| 498 |
342P Social impact of pediatric acute myeloid leukaemia (AML) is biggest challenge in eastern India - A demographic, clinical and psychological study
|
Sen, M.
|
|
|
27 |
S9 |
p. ix107
|
artikel
|
| 499 |
392P Solitary extramedullary plasmacytoma (SEMP) of head and neck: An individual patient data meta-analysis of 315 patients
|
Venkatesulu, B.P.
|
|
|
27 |
S9 |
p. ix121
|
artikel
|
| 500 |
33P Somatic mutations of PIK3CA and AKT1 in Japanese breast cancer
|
Shimoi, T.
|
|
|
27 |
S9 |
p. ix10
|
artikel
|
| 501 |
245P SOX15 expression was associated with poor prognosis in patients with esophageal squamous cell carcinoma: An Iranian cohort study conducted over 10 years
|
Shahidsales, S.
|
|
|
27 |
S9 |
p. ix77
|
artikel
|
| 502 |
123P Stabilization of SDCBP oncoprotein and aiding breast cancer growth and metastasis: The role of A2BP1
|
Chatterjee, A.
|
|
|
27 |
S9 |
p. ix37
|
artikel
|
| 503 |
165P Standardized incidence and associated factors for thyroid cancer in diabetic patients: a population-based analysis
|
Wong, C.K.H.
|
|
|
27 |
S9 |
p. ix52
|
artikel
|
| 504 |
554P Study on the differentially expressed miRNA of drug- contained serum of Bushen decoction on breast cancer bearing nude mice osteoblast by miRNA array
|
Cai, D.
|
|
|
27 |
S9 |
p. ix180
|
artikel
|
| 505 |
248P Substantial RUNX3 expression and co-existence with EZH2 in esophageal cancer: a new finding in Indian esophageal cancer patients
|
Rehman, A.U.
|
|
|
27 |
S9 |
p. ix78
|
artikel
|
| 506 |
240P Surgicaloutcomeoftheelderlywithgastriccancer
|
Kim, S.
|
|
|
27 |
S9 |
p. ix75
|
artikel
|
| 507 |
566P Survey of medical oncology status in Korea (SOMOS-K): A national survey of medical oncologists in the Korean Association for Clinical Oncology (KACO)
|
Kim, D.Y.
|
|
|
27 |
S9 |
p. ix184
|
artikel
|
| 508 |
157P Survey of the onset of the dose limiting toxicity in oncology phase I trial: How long should we assess the toxicity profiles in the era of molecular targeted drug development?
|
Kobayashi, N.
|
|
|
27 |
S9 |
p. ix49
|
artikel
|
| 509 |
210P Survival outcomes after toxicity-related dose modification of 5-fluorouracil, leucovorin and oxalipatin (FOLFOX) in stage III, resected colorectal cancer patients
|
Ha, F.J.
|
|
|
27 |
S9 |
p. ix65
|
artikel
|
| 510 |
328P Survival outcomes in patients with stage IVB, persistent or recurrent adenocarcinoma of the cervix treated with combination chemotherapy
|
Anantawat, T.
|
|
|
27 |
S9 |
p. ix102
|
artikel
|
| 511 |
120P Survival outcomes of metastatic breast cancer who have been treated with bevacizumab and eribulin in the real world. - BEV 1 PTX followed by eribulin versus the reverse sequence
|
Matsui, K.
|
|
|
27 |
S9 |
p. ix36
|
artikel
|
| 512 |
432P Survival pattern of non-metastatic non-small cell lung cancer (NSCLC) in the United States
|
Meshref, A.
|
|
|
27 |
S9 |
p. ix137
|
artikel
|
| 513 |
354P Survival trends of primary testicular diffuse large B-cell lymphoma: A population-based study
|
Mousa, M.
|
|
|
27 |
S9 |
p. ix110
|
artikel
|
| 514 |
373P Synchronous or metachronous esophageal cancer is associated with a lower survival rate in patients with head and neck squamous cell carcinoma
|
Kim, H.M.
|
|
|
27 |
S9 |
p. ix116
|
artikel
|
| 515 |
331P Synergistic effects of ferula gummosa and radiotherapy to induce cytotoxicity and apoptosis in the hela cell line
|
Fani-Pakdel, A.
|
|
|
27 |
S9 |
p. ix103
|
artikel
|
| 516 |
127P Synergistic role of HIF-1a and Nav1.5 in potentiating breast cancer metastasis
|
Dewadas, H.D.
|
|
|
27 |
S9 |
p. ix38
|
artikel
|
| 517 |
390P Systematic review and meta-analysis of pediatric head and neck squamous cell carcinoma (PHNSCC): An analysis of 217 cases
|
Venkatesulu, B.P.
|
|
|
27 |
S9 |
p. ix121
|
artikel
|
| 518 |
555P Systems-wide bioinformatics analysis using next generation transcriptome and proteomics reveals nicotinamide transforms molecular signaling networks toward an antitumor growth: A novel anti-cancer agent in triple negative breast cancer
|
Ryu, H.
|
|
|
27 |
S9 |
p. ix180
|
artikel
|
| 519 |
5P Targeted degradation of anaplastic lymphoma kinase by target degraducer in non-small cell lung cancer
|
Hwang, J.Y.
|
|
|
27 |
S9 |
p. ix2
|
artikel
|
| 520 |
561P Targeted sequencing of plasma ctDNAs and primary tumors identified heterogeneity and homogeneity in advanced gastric cancer
|
Gao, J.
|
|
|
27 |
S9 |
p. ix182
|
artikel
|
| 521 |
357P Targeting dual metabolic pathway specifically killed malignant lymphoma cells
|
Wang, T.
|
|
|
27 |
S9 |
p. ix111
|
artikel
|
| 522 |
13P Targeting unfolded protein response sensitizes urothelial carcinoma cells to cisplatin chemotherapy
|
Han, K.S.
|
|
|
27 |
S9 |
p. ix4
|
artikel
|
| 523 |
271P Target therapy treatment patterns on advanced gastrointestinal stromal tumor (GIST) patients: a nation-wide cohort study in Taiwan
|
Chiang, I.-J.
|
|
|
27 |
S9 |
p. ix84
|
artikel
|
| 524 |
18P TC-1 is required for TBC1D3-induced Wnt/beta-catenin accumulation and cell migration in MCF-7 breast cancer cells
|
Zhao, H.
|
|
|
27 |
S9 |
p. ix5
|
artikel
|
| 525 |
575P Temozolomide for concurrent therapy in brain metastases: Is it feasible in a developing country?
|
Aal, M.
|
|
|
27 |
S9 |
p. ix187
|
artikel
|
| 526 |
128P The alteration of p53-pathway gene expression in advanced breast cancer after neoadjuvant chemo- and hormone therapy
|
Wanandi, S.I.
|
|
|
27 |
S9 |
p. ix38
|
artikel
|
| 527 |
246P The association of plasma soluble major histocompatibility complex class I polypeptide-related sequence A (sMICA) level with the pathological complete response (pCR) in locally advanced esophageal squamous cell carcinoma (ESCC)
|
Kuo, H.-Y.
|
|
|
27 |
S9 |
p. ix77
|
artikel
|
| 528 |
72P The different prognostic impact of age according to individual molecular subtypes in breast cancer
|
Eom, Y.H.
|
|
|
27 |
S9 |
p. ix21-ix22
|
artikel
|
| 529 |
243P The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy
|
Zhao, T.
|
|
|
27 |
S9 |
p. ix76
|
artikel
|
| 530 |
188P The efficacy of neoadjuvant chemotherapy in patients with advanced colon cancer
|
Lv, Y.
|
|
|
27 |
S9 |
p. ix59
|
artikel
|
| 531 |
434P The evaluation of lung cancer patients treated with EGFR-TKI gefitinib as first-line treatment: The Indonesian experience
|
Febriani, A.
|
|
|
27 |
S9 |
p. ix138
|
artikel
|
| 532 |
34P The expression and functional role of Cripto-1 in human colorectal cancer
|
Jun, S.
|
|
|
27 |
S9 |
p. ix10
|
artikel
|
| 533 |
479P The impact of initial symptoms on survival time in advanced non-small cell lung cancer
|
Miyawaki, T.
|
|
|
27 |
S9 |
p. ix153-ix154
|
artikel
|
| 534 |
573P The incidence of post-transplant malignancies in kidney transplantation recipients in King Chulalongkorn Memorial Hospital: A single institute with 44 year's experience in Thailand
|
Uttamapinan, S.
|
|
|
27 |
S9 |
p. ix186
|
artikel
|
| 535 |
158P The inhibitory effects of canstatin on VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model
|
Bae, M.G.
|
|
|
27 |
S9 |
p. ix49
|
artikel
|
| 536 |
160P The inhibitory effects of recombinant canstatin and 3- oacetyloleanolic acid on angiopoietin-1-induced lymphangiogenesis
|
Hwang-Bo, H.
|
|
|
27 |
S9 |
p. ix50
|
artikel
|
| 537 |
544P The number of negative lymph node was an indicator on the extent of lymphadenectomy in middle thoracic esophageal squamous cell carcinoma
|
Zhang, J.
|
|
|
27 |
S9 |
p. ix177
|
artikel
|
| 538 |
467P The prognostic value of Serum Cripto-1 in patients with non-small cell lung
|
Ahn, M.-J.
|
|
|
27 |
S9 |
p. ix150
|
artikel
|
| 539 |
87P Therapeutic effect of harmonic scalpel versus electrocautery in axillary dissection of breast cancer
|
Dong, W.
|
|
|
27 |
S9 |
p. ix25-ix26
|
artikel
|
| 540 |
179P The results of neoadjuvant chemoradiation therapy in combined treatment of rectal cancer
|
Abdujapparov, A.S.
|
|
|
27 |
S9 |
p. ix56
|
artikel
|
| 541 |
581P The RGCIRC Biorepository: Accelerating cancer research to seek tomorrow cure
|
Yadav, B.K.
|
|
|
27 |
S9 |
p. ix188-ix189
|
artikel
|
| 542 |
341P The role and significance of myeloid-derived suppressor cells-like blasts in immune-tolerance of acute myeloid leukemia
|
Hyun, S.Y.
|
|
|
27 |
S9 |
p. ix106-ix107
|
artikel
|
| 543 |
49P The role of circulating cell-free DNA measured by a simple fluorescent assay to predict relapse in triple negative breast cancer receiving neoadjuvant chemotherapy
|
Park, K.
|
|
|
27 |
S9 |
p. ix14
|
artikel
|
| 544 |
531P The role of diuretics in treatment of aromatase inhibitors induced musculoskeletal symptoms in women with non metastatic breast cancer
|
Alhanafy, A.M.
|
|
|
27 |
S9 |
p. ix172-ix173
|
artikel
|
| 545 |
253P The role of MiR-221 in regulating gastric cancer radiation sensitivity
|
Li, G.
|
|
|
27 |
S9 |
p. ix79
|
artikel
|
| 546 |
352P The role of radiotherapy in early-stage primary diffuse large B-cell lymphoma of the Waldeyer's Ring: A retrospective cohort study
|
Lee, S.F.
|
|
|
27 |
S9 |
p. ix110
|
artikel
|
| 547 |
323P The role of SUVmax in 18F-FDG PET/CT for assessing radiation therapy response for cervical cancer
|
Lee, S.H.
|
|
|
27 |
S9 |
p. ix100-ix101
|
artikel
|
| 548 |
280P The study of drug resistant in bladder cancer and its modulation by phytochemicals
|
Zhuo, J.R.
|
|
|
27 |
S9 |
p. ix87
|
artikel
|
| 549 |
276P The survival impact of stromal tumor-infiltrating lymphocytes for patients with metastatic urothelial carcinoma treated with cisplatin-based chemotherapy
|
Hsieh, M.-C.
|
|
|
27 |
S9 |
p. ix86
|
artikel
|
| 550 |
382P The therapeutic changes influence on the treatment results of the hypopharyngeal cancer
|
Yuasa-Nakagawa, K.
|
|
|
27 |
S9 |
p. ix118
|
artikel
|
| 551 |
289P The treatment outcome of metastatic prostate cancer patients treated with androgen deprivation therapy in University Malaya Medical Centre
|
Yehgambaram, P.
|
|
|
27 |
S9 |
p. ix91
|
artikel
|
| 552 |
539P The use of G8 as a screening tool in a tertiary Asian cancer centre
|
Kanesvaran, R.
|
|
|
27 |
S9 |
p. ix175
|
artikel
|
| 553 |
259P Thromboembolism incidence in patients with pancreatic cancer receiving chemotherapy: A single-institutional retrospective cohort analysis
|
Matsuda, C.
|
|
|
27 |
S9 |
p. ix81
|
artikel
|
| 554 |
543P Thromboembolism in gastrointestinal tract cancer patients receiving chemotherapy: Preplanned analysis of risk factors and survival
|
Oba, A.
|
|
|
27 |
S9 |
p. ix176
|
artikel
|
| 555 |
580P To asses the knowledge, attitude and practice [KAP] of paramedical staff towards chemotherapy drugs and their administration and effect of a capsule course on the same
|
Pathak, A.
|
|
|
27 |
S9 |
p. ix188
|
artikel
|
| 556 |
146P Tolerability and pharmacokinetics (PK) of ABT-414 in Japanese patients (pts) with recurrent malignant glioma
|
Narita, Y.
|
|
|
27 |
S9 |
p. ix44
|
artikel
|
| 557 |
269P Transarterial ethanol ablation combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
|
Yang, B.
|
|
|
27 |
S9 |
p. ix83
|
artikel
|
| 558 |
283P Treatment outcomes and toxicity of sunitinib in advanced renal cell carcinoma patients
|
Saied, N.M.
|
|
|
27 |
S9 |
p. ix88
|
artikel
|
| 559 |
374P Trends in incidence of head and neck cancers in India
|
Francis, C.J.K.
|
|
|
27 |
S9 |
p. ix116
|
artikel
|
| 560 |
61P Tumor-infiltrating lymphocytes/macrophages and clinical outcome in breast cancer
|
Kim, Y.-S.
|
|
|
27 |
S9 |
p. ix17-ix18
|
artikel
|
| 561 |
197P Tumor-infiltrating lymphocytes predict the chemotherapeutic outcomes in patients with stage IV colorectal cancer
|
Shibutani, M.
|
|
|
27 |
S9 |
p. ix61-ix62
|
artikel
|
| 562 |
416P Typical morphological features revealed unfavorable survival benefits in high-grade neuroendocrine carcinomas
|
Zhai, H.-R.
|
|
|
27 |
S9 |
p. ix130
|
artikel
|
| 563 |
541P Understanding barriers of Indonesian breast cancer patients seeking for treatment: Focus on depression and anxiety
|
Vatvani, A.D.
|
|
|
27 |
S9 |
p. ix175
|
artikel
|
| 564 |
53P Update results of a novel assay for the detection of methylated CpGs from sputum to screen patients with lung cancer
|
Nagasaka, T.
|
|
|
27 |
S9 |
p. ix15
|
artikel
|
| 565 |
198P Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer
|
Au, L.
|
|
|
27 |
S9 |
p. ix62
|
artikel
|
| 566 |
516P Utility of colonoscopy in diagnosing familial adenomatous polyposis (FAP) among patients (pts) with desmoid tumors (DT)
|
Zhang, Z.
|
|
|
27 |
S9 |
p. ix167
|
artikel
|
| 567 |
453P Utility of re-biopsy and clinical predictive factors of T790M point mutation in EGFR mutated non-small lung cancer
|
Kirita, K.
|
|
|
27 |
S9 |
p. ix146
|
artikel
|
| 568 |
461P Validation of a modified lung graded prognostic assessment as a tool for survival in NSCLC patients with brain metastases
|
Xie, M.
|
|
|
27 |
S9 |
p. ix148
|
artikel
|
| 569 |
548P Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor
|
Kim, H.S.
|
|
|
27 |
S9 |
p. ix178
|
artikel
|
| 570 |
20P Verification of mechanism that CSC markers are implicated in poor prognosis for pancreatic ductal adenocarcinoma
|
Arima, K.
|
|
|
27 |
S9 |
p. ix6
|
artikel
|
| 571 |
512P VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
|
Moon, J.Y.
|
|
|
27 |
S9 |
p. ix166
|
artikel
|
| 572 |
576P Wilms tumor gene (WT-1) expression in female patients with unfavorable subset of cancer of unknown primary site
|
Kodaira, M.
|
|
|
27 |
S9 |
p. ix187
|
artikel
|
| 573 |
The European Society for Medical Oncology (ESMO)
|
|
|
|
27 |
S9 |
p. v
|
artikel
|
| 574 |
414TiP An open-label phase 2a study of combination dabrafenib (D) and trametinib (T) in Asian patients (pts) with advanced BRAF V600-mutant acral lentiginous melanoma (ALM) or cutaneous melanoma (CM)
|
Guo, J.
|
|
|
27 |
S9 |
p. ix129
|
artikel
|
| 575 |
218TiP A phase Ib study of irinotecan, bevacizumab and biweekly TAS-102 in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidine and oxaliplation (MODURATE)
|
Taniguchi, H.
|
|
|
27 |
S9 |
p. ix67
|
artikel
|
| 576 |
137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
|
Iwata, H.
|
|
|
27 |
S9 |
p. ix41
|
artikel
|
| 577 |
393TiP A phase II trial of nedaplatin, 5-fluorouracil and docetaxel for induction chemotherapy with local advanced squamous cell carcinoma of the head and neck
|
Ueda, S.
|
|
|
27 |
S9 |
p. ix121-ix122
|
artikel
|
| 578 |
483TiP A Phase (Ph) III clinical program: 1L atezolizumab (atezo) plus chemotherapy (chemo) in chemo-naive advanced NSCLC
|
Mok, T.S.K.
|
|
|
27 |
S9 |
p. ix155-ix156
|
artikel
|
| 579 |
274TiP A randomized phase 2 study of nanoliposomal irinotecan (nal-IRI, BAX2398)-containing regimen in Japanese patients with metastatic pancreatic adenocarcinoma (mPAC)
|
Ioka, T.
|
|
|
27 |
S9 |
p. ix84-ix85
|
artikel
|
| 580 |
481TiP Checkmate 722: A phase 3 trial of nivolumab with chemotherapy or ipilimumab vs chemotherapy in epidermal growth factor receptor (EGFR)-mutation, T790M-negative stage IV or recurrent non-small cell lung cancer (NSCLC) after EGFR tyrosine kinase inhibitor (TKI) therapy
|
Nakagawa, K.
|
|
|
27 |
S9 |
p. ix154-ix155
|
artikel
|
| 581 |
403TiP CREAM study: Clinical correlation between ipilimumab- Related colitis And intestinal Microbiote in metastatic melanoma patients
|
Orgiano, L.
|
|
|
27 |
S9 |
p. ix125
|
artikel
|
| 582 |
285TiP DANUBE: A Phase 3 randomised study of first-line durvalumab (MEDI4736) 6 tremelimumab vs standard of care (SoC) chemotherapy (CT) in patients (pts) with Stage IV urothelial carcinoma (UC)
|
Park, S.H.
|
|
|
27 |
S9 |
p. ix88-ix89
|
artikel
|
| 583 |
217TiP Dose-finding phase Ib study of FOLFOXIRI plus ramucirumabas first-line therapy for patients with metastatic colorectal cancer
|
Yamazaki, K.
|
|
|
27 |
S9 |
p. ix66-ix67
|
artikel
|
| 584 |
482TiP Global, Phase 3 study of first-line durvalumab (MEDI4736) + tremelimumab vs standard of care platinum-based chemotherapy in advanced/metastatic NSCLC: NEPTUNE
|
Mok, T.
|
|
|
27 |
S9 |
p. ix155
|
artikel
|
| 585 |
136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC
|
Emens, L.
|
|
|
27 |
S9 |
p. ix40
|
artikel
|
| 586 |
521TiP IMpower133: A phase I/III study of atezolizumab (atezo) with carboplatin (carbo) and etoposide as 1L therapy in patients (pts) with extensive-stage SCLC (ES-SCLC)
|
Mok, T.S.K.
|
|
|
27 |
S9 |
p. ix169
|
artikel
|
| 587 |
429TiP IMpower010: A Phase III trial investigating atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy (chemo) in patients (pts) with completely resected NSCLC
|
Zhou, C.
|
|
|
27 |
S9 |
p. ix135
|
artikel
|
| 588 |
480TiP IMpower110: Phase III study on 1L atezolizumab (atezo) in PD-L1–selected chemotherapy (chemo)-naive NSCLC patients (pts)
|
De Marinis, F.
|
|
|
27 |
S9 |
p. ix154
|
artikel
|
| 589 |
394TiP KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma
|
Chan, A.T.C.
|
|
|
27 |
S9 |
p. ix122
|
artikel
|
| 590 |
164TiP Phase I study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer
|
Laetsch, T.W.
|
|
|
27 |
S9 |
p. ix51
|
artikel
|
| 591 |
Title Page
|
|
|
|
27 |
S9 |
p. iii
|
artikel
|
| 592 |
translational research index
|
|
|
|
27 |
S9 |
p. ix194-ix195
|
artikel
|
Tijdschrift beschrijving